[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 255
6. Jha A, Sayami G, Shrestha A: A rare case of juvenile fibrosarcoma of eyelid. JNMA J Nepal Med Assoc; 2007 Apr-Jun;46(166):49-51
Genetic Alliance. consumer health - Fibrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A rare case of juvenile fibrosarcoma of eyelid.
  • Juvenile fibrosarcoma is not an uncommon tumor in children; however, eyelid involvement is extremely rare.
  • Histologically, it is similar to adult fibrosarcoma but it has an excellent prognosis.
  • Here we present a case of juvenile fibrosarcoma of the eyelid in a four year female child presenting with a rapidly enlarging, painless, left upper eyelid mass.
  • An incisional biopsy, from the eyelid mass, showed typical histopathological features of juvenile fibrosarcoma.
  • [MeSH-major] Eyelid Neoplasms / pathology. Eyelids / pathology. Fibrosarcoma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18094736.001).
  • [ISSN] 0028-2715
  • [Journal-full-title] JNMA; journal of the Nepal Medical Association
  • [ISO-abbreviation] JNMA J Nepal Med Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Nepal
  •  go-up   go-down


7. Testa AC, Gaurilcikas A, Licameli A, Mancari R, Di Legge A, Malaggese M, Mascilini F, Zannoni GF, Scambia G, Ferrandina G: Sonographic features of primary ovarian fibrosarcoma: a report of two cases. Ultrasound Obstet Gynecol; 2009 Jan;33(1):112-5
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sonographic features of primary ovarian fibrosarcoma: a report of two cases.
  • Two cases of primary cellular fibroblastic tumor of the ovary are described, which presented a challenging clinical and histopathological differential diagnosis of primary ovarian fibrosarcoma and mitotically active cellular fibroma.
  • Histopathological examination of the first case was characterized by the presence of hemorrhage, necrosis and severe nuclear atypia, with a metastatic peritoneal lesion, and the eventual diagnosis was primary ovarian fibrosarcoma.
  • We speculate that ovarian fibrosarcoma at the preoperative examination might be considered in the differential diagnosis whenever a unilateral, heterogeneous, largely round solid ovarian lesion is detected.
  • [MeSH-major] Fibroma / ultrasonography. Fibrosarcoma / ultrasonography. Ovarian Neoplasms / ultrasonography
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Middle Aged

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2008 ISUOG.
  • (PMID = 19072774.001).
  • [ISSN] 1469-0705
  • [Journal-full-title] Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
  • [ISO-abbreviation] Ultrasound Obstet Gynecol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


8. Ossendorf C, Studer GM, Bode B, Fuchs B: Sclerosing epithelioid fibrosarcoma: case presentation and a systematic review. Clin Orthop Relat Res; 2008 Jun;466(6):1485-91
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sclerosing epithelioid fibrosarcoma: case presentation and a systematic review.
  • In sclerosing epithelioid fibrosarcoma (SEF), a rare variant of low-grade fibrosarcoma, treatment results and therapeutic options are poorly characterized.
  • [MeSH-major] Bone Neoplasms / pathology. Fibrosarcoma / pathology. Ulna
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1999 Nov;23(11):1423-8 [10555013.001]
  • [Cites] Cancer Genet Cytogenet. 1998 Dec;107(2):102-6 [9844602.001]
  • [Cites] Ann Pathol. 2000 Mar;20(2):154-7 [10740014.001]
  • [Cites] Cancer Genet Cytogenet. 2000 Jun;119(2):127-31 [10867148.001]
  • [Cites] Neurosurgery. 2000 Oct;47(4):956-9; discussion 959-60 [11014436.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10):1353-60 [11023096.001]
  • [Cites] Eur J Surg Oncol. 2001 Feb;27(1):121-2 [11237504.001]
  • [Cites] Ultrastruct Pathol. 2001 Jan-Feb;25(1):31-7 [11297317.001]
  • [Cites] J Clin Pathol. 2001 Sep;54(9):721-3 [11533083.001]
  • [Cites] Cesk Patol. 2001 Nov;37(4):158-62 [11813633.001]
  • [Cites] Int J Surg Pathol. 2002 Jul;10(3):211-6 [12232578.001]
  • [Cites] Int J Surg Pathol. 2002 Jul;10(3):227-30 [12232581.001]
  • [Cites] Pathologe. 2003 Mar;24(2):103-8 [12673498.001]
  • [Cites] Pathol Int. 1999 Sep;49(9):820-5 [10504555.001]
  • [Cites] Pathologica. 2004 Oct;96(5):433-5 [15688980.001]
  • [Cites] Ann Otol Rhinol Laryngol. 2005 Feb;114(2):87-9 [15757185.001]
  • [Cites] Ultrastruct Pathol. 2004 Sep-Dec;28(5-6):321-32 [15764580.001]
  • [Cites] Am J Surg Pathol. 2005 May;29(5):653-9 [15832090.001]
  • [Cites] J Colloid Interface Sci. 2002 Jun 15;250(2):444-50 [16290683.001]
  • [Cites] Rev Pneumol Clin. 2006 Jun;62(3):179-82 [16840996.001]
  • [Cites] Histopathology. 2006 Aug;49(2):152-60 [16879392.001]
  • [Cites] Adv Exp Med Biol. 2006;587:99-113 [17163160.001]
  • [Cites] Ann Pathol. 2006 Dec;26(6):419-25 [17255901.001]
  • [Cites] Am J Surg Pathol. 2007 Sep;31(9):1387-402 [17721195.001]
  • [Cites] Arch Pathol Lab Med. 2007 Dec;131(12):1825-8 [18081443.001]
  • [Cites] Ann Pathol. 2003 Apr;23(2):135-48 [12843968.001]
  • [Cites] J Clin Pathol. 2004 Jan;57(1):90-4 [14693846.001]
  • [Cites] Ultrastruct Pathol. 2003 Sep-Oct;27(5):349-55 [14708726.001]
  • [Cites] Histopathology. 2004 Jul;45(1):29-38 [15228441.001]
  • [Cites] Cancer Genet Cytogenet. 2004 Jul 15;152(2):136-40 [15262433.001]
  • [Cites] J Korean Med Sci. 2004 Aug;19(4):619-23 [15308860.001]
  • [Cites] Zhonghua Bing Li Xue Za Zhi. 2004 Aug;33(4):337-41 [15363319.001]
  • [Cites] Virchows Arch. 2004 Oct;445(4):410-3 [15322876.001]
  • [Cites] Am J Clin Pathol. 1987 Nov;88(5):615-9 [3673943.001]
  • [Cites] Histopathology. 1995 Mar;26(3):229-37 [7797200.001]
  • [Cites] Am J Surg Pathol. 1995 Sep;19(9):979-93 [7661286.001]
  • [Cites] Histopathology. 1996 May;28(5):451-5 [8735721.001]
  • [Cites] Skeletal Radiol. 1997 Oct;26(10):619-21 [9361360.001]
  • [Cites] Am J Surg Pathol. 1997 Dec;21(12):1481-8 [9414192.001]
  • [Cites] Am J Surg Pathol. 1998 Nov;22(11):1431-3 [9808138.001]
  • [Cites] Histopathology. 1998 Oct;33(4):354-60 [9822926.001]
  • [Cites] Histopathology. 2000 Jan;36(1):92-3 [10681195.001]
  • (PMID = 18340502.001).
  • [ISSN] 1528-1132
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 45
  • [Other-IDs] NLM/ PMC2384045
  •  go-up   go-down


9. Sahin D, Koç N, Etker S, Güven S, Canpolat C: Congenital pulmonary fibrosarcoma in a newborn with hypoglycemia and respiratory distress: case report. Turk J Pediatr; 2010 May-Jun;52(3):325-9
MedlinePlus Health Information. consumer health - Respiratory Failure.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Congenital pulmonary fibrosarcoma in a newborn with hypoglycemia and respiratory distress: case report.
  • Although primary bronchopulmonary fibrosarcoma is a rare tumor, it may be characterized by the symptoms of acute respiratory distress occurring during the first moments of life in a newborn.
  • It is one of the leading congenital malignant neoplasms of the lung, but is considered a borderline tumor since its biological behavior is much more favorable than that of adult fibrosarcomas.
  • In this case report, we present a case of congenital pulmonary spindle cell tumor showing the features of fibrosarcoma, and we discuss the differential diagnosis of spindle cell lesions localized within the thorax.
  • [MeSH-major] Fibrosarcoma / congenital. Hypoglycemia / etiology. Lung Neoplasms / congenital. Respiratory Insufficiency / etiology


10. Buccoliero AM, Castiglione F, Rossi Degl'Innocenti D, Maio V, Taddei A, Sardi I, Noccioli B, Franchi A, Taddei GL: Congenital/Infantile fibrosarcoma of the colon: morphologic, immunohistochemical, molecular, and ultrastructural features of a relatively rare tumor in an extraordinary localization. J Pediatr Hematol Oncol; 2008 Oct;30(10):723-7
Genetic Alliance. consumer health - Fibrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Congenital/Infantile fibrosarcoma of the colon: morphologic, immunohistochemical, molecular, and ultrastructural features of a relatively rare tumor in an extraordinary localization.
  • Fibrosarcomas diagnosed during the early years of life are called congenital/infantile fibrosarcomas.
  • They differ from adult fibrosarcomas because of their limited aggressive outcome.
  • Congenital/infantile fibrosarcomas occur most frequently on the extremities.
  • This article describes an exceptional case of colonic congenital/infantile fibrosarcoma diagnosed in a 3-day-old baby boy.
  • It is the third intestinal congenital/infantile fibrosarcoma reported in the international literature.
  • The algorithm for the diagnosis of congenital/infantile fibrosarcoma, especially outside the usual localizations, should comprise morphologic, immunohistochemical, molecular, and ultrastructural studies.
  • [MeSH-major] Colonic Neoplasms / congenital. Fibrosarcoma / congenital

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19011467.001).
  • [ISSN] 1536-3678
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Pereira CM, Jorge J Jr, Di Hipólito O Jr, Kowalski LP, Lopes MA: Primary intraosseous fibrosarcoma of jaw. Int J Oral Maxillofac Surg; 2005 Jul;34(5):579-81
Genetic Alliance. consumer health - Fibrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intraosseous fibrosarcoma of jaw.
  • This paper reports one case of primary fibrosarcoma affecting the mandible in a 41-year-old woman.
  • Microscopically, the tumor was cellularized with an intense mitotic activity, and areas of necrosis and hemorrhage, and the cells showed immunoreactivity only for vimentin, establishing the diagnosis of primary intraosseous fibrosarcoma.
  • [MeSH-major] Fibrosarcoma / pathology. Mandibular Neoplasms / pathology
  • [MeSH-minor] Adult. Biopsy. Female. Follow-Up Studies. Humans. Mitosis. Necrosis. Vimentin / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16053882.001).
  • [ISSN] 0901-5027
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Vimentin
  • [Number-of-references] 31
  •  go-up   go-down


12. Hansen T, Katenkamp K, Brodhun M, Katenkamp D: Low-grade fibrosarcoma--report on 39 not otherwise specified cases and comparison with defined low-grade fibrosarcoma types. Histopathology; 2006 Aug;49(2):152-60
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade fibrosarcoma--report on 39 not otherwise specified cases and comparison with defined low-grade fibrosarcoma types.
  • AIMS: Low-grade fibrosarcomas are tumours that mainly affect the extremities and trunk of adults of either sex.
  • Among these, low-grade fibromyxoid sarcoma (FMS), hyalinizing spindle cell tumour with giant collagen rosettes (HST) and sclerosing epithelioid fibrosarcoma (SEF) are well-established entities.
  • These low-grade fibrosarcomas, not otherwise specified (FNOS) were provisionally designated as 'fibrosarcoma, low-grade fibroblastic type'.
  • FNOS exhibited increased atypia and mitotic count compared with the other sarcomas studied [FNOS, mean value 4.6 mitoses/10 high-power field (HPF); FMS, 0.7/10 HPF).
  • CONCLUSIONS: The term 'fibrosarcoma, low-grade fibroblastic type' should be used as a diagnosis of exclusion.
  • Further studies should elucidate whether it represents a distinct fibrosarcoma type.
  • [MeSH-major] Fibroblasts / pathology. Fibrosarcoma / pathology
  • [MeSH-minor] Adult. Age Factors. Aged. Aged, 80 and over. Antigens, CD34 / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Ki-67 Antigen / analysis. Male. Microscopy, Electron. Middle Aged. Neoplasm Recurrence, Local. Terminology as Topic

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16879392.001).
  • [ISSN] 0309-0167
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Ki-67 Antigen
  •  go-up   go-down


13. Plummer JM, Bonadie KO, Williams N, Leake PA, Mitchell DI: Duodenal fibrosarcoma mimicking Franz tumour complicated by post-resection chylous ascites. West Indian Med J; 2010 Jan;59(1):84-7
MedlinePlus Health Information. consumer health - Intestinal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Duodenal fibrosarcoma mimicking Franz tumour complicated by post-resection chylous ascites.
  • Pathology and immunohistochemical analysis of the tumour suggest duodenal fibrosarcoma.
  • [MeSH-major] Chylous Ascites / diagnosis. Duodenal Neoplasms / radiography. Duodenal Neoplasms / surgery. Fibrosarcoma / radiography. Fibrosarcoma / surgery. Postoperative Complications / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Young Adult

  • Genetic Alliance. consumer health - Chylous Ascites.
  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20931921.001).
  • [ISSN] 0043-3144
  • [Journal-full-title] The West Indian medical journal
  • [ISO-abbreviation] West Indian Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Jamaica
  •  go-up   go-down


1
Advertisement
4. Pawlicki J, Król R, Kajor M, Ziaja J: [Case of malignant tumour phyllodes converting to fibrosarcoma]. Pol Merkur Lekarski; 2007 Mar;22(129):215-7
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Case of malignant tumour phyllodes converting to fibrosarcoma].
  • After surgical treatment of recurrent tumours (fibrosarcoma form) occurred two times during 1 year time.
  • [MeSH-major] Breast Neoplasms / pathology. Cell Transformation, Neoplastic / pathology. Fibrosarcoma / pathology. Neoplasm Recurrence, Local / pathology. Phyllodes Tumor / pathology
  • [MeSH-minor] Adult. Female. Follow-Up Studies. Humans. Mastectomy. Reoperation. Treatment Outcome

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17682679.001).
  • [ISSN] 1426-9686
  • [Journal-full-title] Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego
  • [ISO-abbreviation] Pol. Merkur. Lekarski
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


15. Battiata AP, Casler J: Sclerosing epithelioid fibrosarcoma: a case report. Ann Otol Rhinol Laryngol; 2005 Feb;114(2):87-9
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sclerosing epithelioid fibrosarcoma: a case report.
  • Sclerosing epithelioid fibrosarcoma (SEF) is a rare variant of fibrosarcoma.
  • Sclerosing epithelioid fibrosarcoma is a rare neoplasm that is now listed among the low-grade neoplasms that may occur in the head and neck.
  • [MeSH-major] Fibrosarcoma / pathology. Fibrosarcoma / surgery. Head and Neck Neoplasms / pathology. Head and Neck Neoplasms / surgery
  • [MeSH-minor] Adult. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15757185.001).
  • [ISSN] 0003-4894
  • [Journal-full-title] The Annals of otology, rhinology, and laryngology
  • [ISO-abbreviation] Ann. Otol. Rhinol. Laryngol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Tsuchido K, Yamada M, Satou T, Otsuki Y, Shimizu S, Kobayashi H: Cytology of sclerosing epithelioid fibrosarcoma in pleural effusion. Diagn Cytopathol; 2010 Oct;38(10):748-53
Genetic Alliance. consumer health - Fibrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytology of sclerosing epithelioid fibrosarcoma in pleural effusion.
  • We report a case of sclerosing epithelioid fibrosarcoma focusing on its cytological features in pleural effusion.
  • The histological diagnosis was sclerosing epithelioid fibrosarcoma with a negative surgical margin.
  • A histological examination revealed a metastasis of sclerosing epithelioid fibrosarcoma, and chemotherapy was initiated.
  • The above cytological features, coupled with the clinical findings, enabled a diagnosis of sclerosing epithelioid fibrosarcoma.
  • To our knowledge, this is the first cytological description of sclerosing epithelioid fibrosarcoma.
  • [MeSH-major] Cytodiagnosis. Fibrosarcoma / secondary. Pleural Effusion, Malignant / pathology
  • [MeSH-minor] Adult. Buttocks / pathology. Epithelioid Cells / pathology. Humans. Immunohistochemistry. Lung Neoplasms / secondary. Male. Sclerosis / pathology. Soft Tissue Neoplasms / secondary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 Wiley-Liss, Inc.
  • (PMID = 20091700.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Sassi SH, Dhouib R, Ben Dhaou S, Mrad K, Driss M, Abbes I, Arbi H, Haourai H, Ben Romdhane K: [Sclerosing epithelioid fibrosarcoma. A case report]. Rev Chir Orthop Reparatrice Appar Mot; 2008 Feb;94(1):92-5
Genetic Alliance. consumer health - Fibrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Sclerosing epithelioid fibrosarcoma. A case report].
  • Sclerosing epithelioid fibrosarcoma is a rare variant of fibrosarcomas, which was recently identified as a separate entity due to specific histologic and immunohistochemistry features and its poor prognosis.
  • We report a case of sclerosing epithelioid fibrosarcoma of soft tissues, which developed in a 37-year-old woman who presented a tumor involving the posteromedial aspect of the left knee and which progressed in size for one year.
  • Histology of the tumorectomy specimen and the immunohistochemistry study led to the diagnosis of sclerosing epithelioid fibrosarcoma of soft tissues.
  • [MeSH-major] Fibrosarcoma / diagnosis. Knee. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18342037.001).
  • [ISSN] 0035-1040
  • [Journal-full-title] Revue de chirurgie orthopédique et réparatrice de l'appareil moteur
  • [ISO-abbreviation] Rev Chir Orthop Reparatrice Appar Mot
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


18. Adeleye AO, Fellig Y, Umansky F, Shoshan Y: Rapid growth of primary cerebral fibrosarcoma with conversion to glioblastoma at second recurrence. J Neurooncol; 2009 Apr;92(2):233-8
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rapid growth of primary cerebral fibrosarcoma with conversion to glioblastoma at second recurrence.
  • We present a case of de novo fibrosarcoma in a 43-year-old male, with MRI documented evolution from a 5 mm hyperintense area to 5 cm tumor mass in a 12-month period.
  • The diagnosis of low-grade fibrosarcoma was established by three experienced neuropathologists.
  • [MeSH-major] Brain Neoplasms / pathology. Fibrosarcoma / pathology. Glioblastoma / pathology. Neoplasms, Second Primary / pathology
  • [MeSH-minor] Adult. Combined Modality Therapy. Humans. Magnetic Resonance Imaging. Male. Neurosurgical Procedures. Radiosurgery. Radiotherapy, Conformal

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • Genetic Alliance. consumer health - Glioblastoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1969 Aug;24(2):270-6 [4307749.001]
  • [Cites] Cancer. 1995 Jun 15;75(12):2910-8 [7773942.001]
  • [Cites] Surg Neurol. 2003 Dec;60(6):579-83; discussion 583-4 [14670686.001]
  • [Cites] Cancer. 1993 Dec 1;72(11):3277-81 [8242554.001]
  • [Cites] Am J Surg Pathol. 2002 Aug;26(8):1056-63 [12170093.001]
  • [Cites] Pediatr Neurosurg. 2000 Nov;33(5):257-260 [11155063.001]
  • [Cites] Childs Nerv Syst. 2002 Nov;18(11):648-51 [12420128.001]
  • [Cites] Acta Neuropathol. 1973;23(4):334-7 [4718200.001]
  • [Cites] Neurosurgery. 1995 Apr;36(4):685-90 [7596497.001]
  • [Cites] Cancer. 1979 Jan;43(1):246-57 [216476.001]
  • [Cites] Acta Neurochir (Wien). 1997;139(7):684-9 [9265963.001]
  • [Cites] J Neurooncol. 2004 Jun;68(2):161-7 [15218953.001]
  • [Cites] J Neurosurg. 1989 Jul;71(1):77-82 [2661743.001]
  • (PMID = 19082530.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Bahrami A, Folpe AL: Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period. Am J Surg Pathol; 2010 Oct;34(10):1504-13
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period.
  • Adult-type fibrosarcoma (FS) was once considered the most common adult sarcoma, but is now considered a diagnosis of exclusion.
  • One hundred ninety-five cases diagnosed as adult FS in somatic soft tissue were retrieved from our institutional archives for the period 1960 to 2008.
  • Fluorescence in situ hybridization analysis for SYT gene rearrangement was done in 6 putative CK-negative synovial sarcomas (SS).
  • Non-FS (137 cases) were reclassified as: undifferentiated pleomorphic sarcoma (32 cases), SS (21 cases), solitary fibrous tumor (14 cases), myxofibrosarcoma (11 cases), malignant peripheral nerve sheath tumor (8 cases), FS dermatofibrosarcoma protuberans, and desmoplastic melanoma (4 cases each), low-grade fibromyxoid sarcoma, sarcomatoid carcinoma, desmoid-type fibromatosis, rhabdomyosarcoma, myofibroblastic sarcoma, spindle-cell liposarcoma (3 cases each), sclerosing epithelioid FS, fibroma-like epithelioid sarcoma, leiomyosarcoma, cellular fibrous histiocytoma (2 cases each), and others (17 cases).
  • Exclusive of undifferentiated pleomorphic sarcoma, the distinction of which from FS is subjective, 64% of putative FS were reclassified, most commonly as monophasic SS and solitary fibrous tumor.
  • We conclude that true FS is exceedingly rare, accounting for <1% of approximately 10,000 adult soft tissue sarcomas seen at our institution during this time period, and should be diagnosed with great caution.
  • [MeSH-major] Fibrosarcoma / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Child. Child, Preschool. DNA, Neoplasm / analysis. Female. Gene Rearrangement. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged. Minnesota / epidemiology. Proto-Oncogene Proteins / genetics. Proto-Oncogene Proteins / metabolism. Repressor Proteins / genetics. Repressor Proteins / metabolism. Young Adult

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20829680.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DNA, Neoplasm; 0 / Proto-Oncogene Proteins; 0 / Repressor Proteins; 0 / SS18 protein, human
  •  go-up   go-down


20. Daimon T, Tajima S, Bando M, Ohno S, Hironaka M, Sugiyama Y: [A case of primary fibrosarcoma of the pulmonary artery]. Nihon Kokyuki Gakkai Zasshi; 2006 Apr;44(4):319-24
Genetic Alliance. consumer health - Fibrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of primary fibrosarcoma of the pulmonary artery].
  • The tumor was diagnosed as sarcoma by transbronchial biopsy.
  • The autopsy revealed primary pulmonary artery sarcoma: fibrosarcoma arising from the left pulmonary artery.
  • To our knowledge, this is the first case report of fibrosarcoma of the pulmonary artery in Japan.
  • [MeSH-major] Fibrosarcoma / etiology. Pulmonary Artery. Vascular Neoplasms / etiology
  • [MeSH-minor] Adult. Humans. Japan / epidemiology. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16681248.001).
  • [ISSN] 1343-3490
  • [Journal-full-title] Nihon Kokyūki Gakkai zasshi = the journal of the Japanese Respiratory Society
  • [ISO-abbreviation] Nihon Kokyuki Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


21. Kobayashi K, Murakami R, Fujii T, Hirano A: Malignant transformation of ameloblastic fibroma to ameloblastic fibrosarcoma: case report and review of the literature. J Craniomaxillofac Surg; 2005 Oct;33(5):352-5
Genetic Alliance. consumer health - Fibrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant transformation of ameloblastic fibroma to ameloblastic fibrosarcoma: case report and review of the literature.
  • INTRODUCTION: Ameloblastic fibrosarcoma is a rare malignant odontogenic tumour and is regarded as the malignant counterpart of the ameloblastic fibroma.
  • PATIENT: The case of a 26-year-old man who underwent curettage of an ameloblastic fibroma and died of an ameloblastic fibrosarcoma is presented, and the course of malignant transformation is analysed retrospectively.
  • CONCLUSION: One-third of ameloblastic fibrosarcoma cases seem to have developed from recurrent ameloblastic fibromas.
  • Knowledge of the malignant potential in the mesenchymal spindle cells of ameloblastic fibroma will assist in determining the management of these benign tumours, and may prevent malignant transformation to ameloblastic fibrosarcoma.
  • [MeSH-minor] Adult. Fatal Outcome. Follow-Up Studies. Fractures, Spontaneous / pathology. Humans. Male. Mandibular Fractures / pathology. Neoplasm Recurrence, Local / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16129612.001).
  • [ISSN] 1010-5182
  • [Journal-full-title] Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
  • [ISO-abbreviation] J Craniomaxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Scotland
  • [Number-of-references] 16
  •  go-up   go-down


22. Blizniukov OP, Smirnova EA: [Sclerosing epithelial fibrosarcoma: a clinico-morphological evaluation of 10 cases]. Vopr Onkol; 2009;55(5):586-93
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Sclerosing epithelial fibrosarcoma: a clinico-morphological evaluation of 10 cases].
  • Sclerosing epithelial fibrosarcoma is a malignant mesenchymal tumor (fibroblastic class).
  • Differentiated analysis of epithelioid fibrosarcoma may also be done by computed microscopy and immunomorphology using other tumor models consisting of light-cytoplasm epitheloid cells, mostly osteosarcoma, clear-cell renal carcinoma, melanoma, synovial sarcoma and clear-cell sarcoma of the tendon sheath and aponeurosis.
  • [MeSH-major] Biomarkers, Tumor / analysis. Epithelioid Cells / pathology. Fibrosarcoma / diagnosis
  • [MeSH-minor] Abdomen. Adult. Back. Female. Humans. Leg. Male. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Sclerosis. Thorax

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20020654.001).
  • [ISSN] 0507-3758
  • [Journal-full-title] Voprosy onkologii
  • [ISO-abbreviation] Vopr Onkol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


23. Choi WJ, Ha MT, Shin JK, Lee JH: Primary ovarian fibrosarcoma with long-term survival: a report of two cases. J Obstet Gynaecol Res; 2006 Oct;32(5):524-8
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary ovarian fibrosarcoma with long-term survival: a report of two cases.
  • We report on two cases of primary ovarian fibrosarcoma detected in two women aged 44 and 34 years old.
  • [MeSH-major] Fibrosarcoma / diagnosis. Ovarian Neoplasms / diagnosis
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Fallopian Tubes / surgery. Female. Humans. Hysterectomy. Immunohistochemistry. Omentum / surgery. Ovariectomy. Prognosis. Receptors, Progesterone / analysis. Vimentin / analysis

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16984523.001).
  • [ISSN] 1341-8076
  • [Journal-full-title] The journal of obstetrics and gynaecology research
  • [ISO-abbreviation] J. Obstet. Gynaecol. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Receptors, Progesterone; 0 / Vimentin
  •  go-up   go-down


24. Santi CG, Flores RS, Medina MM, Maruta CW, Aoki V, Anhalt G, Rivitti EA: Paraneoplastic pemphigus associated with pelvic inflammatory fibrosarcoma: a case report. J Dermatol; 2005 Dec;32(12):1014-20
MedlinePlus Health Information. consumer health - Pemphigus.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paraneoplastic pemphigus associated with pelvic inflammatory fibrosarcoma: a case report.
  • An exploratory laparotomy revealed a pelvic mass and the histologic examination showed an inflammatory fibrosarcoma.
  • [MeSH-major] Fibrosarcoma / pathology. Paraneoplastic Syndromes / pathology. Pelvic Neoplasms / pathology. Pemphigus / pathology
  • [MeSH-minor] Adult. African Americans. Biopsy, Needle. Female. Follow-Up Studies. Humans. Immunohistochemistry. Laparotomy / methods. Risk Assessment. Treatment Outcome

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • Genetic Alliance. consumer health - Pemphigus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16471469.001).
  • [ISSN] 0385-2407
  • [Journal-full-title] The Journal of dermatology
  • [ISO-abbreviation] J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 29
  •  go-up   go-down


25. Plotti F, Di Donato V, Zullo MA, Angioli R, Panici PB: An unusual case of secondary fibrosarcoma after treatment for breast cancer. Gynecol Oncol; 2006 Dec;103(3):1133-6
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual case of secondary fibrosarcoma after treatment for breast cancer.
  • BACKGROUND: Post-irradiation breast sarcoma is a rare and highly aggressive tumor, associated with poor prognosis.
  • However, the mean latent periods reported for postradiation sarcomas after treatment of breast cancer ranges from 5 to 10 years.
  • CASE: We present a rare case of fibrosarcoma of the axilla, diagnosed 23 months after breast surgery and irradiation for medullary poorly differentiated carcinoma, treated with wide local excision with resection of the serratus anterior muscle until pleural wall.
  • CONCLUSION: This case confirm a possible early appearance of sarcoma in the irradiation field after radiotherapy.
  • Thus, when a nodule appears in the irradiation field even if within 2 years after radiotherapy, physician should be alert for a possible sarcoma and wide biopsy with histologic confirmation is auspicable.
  • [MeSH-major] Axilla. Breast Neoplasms / radiotherapy. Carcinoma, Medullary / radiotherapy. Fibrosarcoma / diagnosis. Neoplasms, Radiation-Induced / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Radiotherapy / adverse effects

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • Genetic Alliance. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16919710.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 17
  •  go-up   go-down


26. Durin L, Jeanne-Pasquier C, Bailleul P, Eboué C, Aicardi S, Herlicoviez M, Dreyfus M: Prenatal diagnosis of a fibrosarcoma of the thigh: a case report. Fetal Diagn Ther; 2006;21(6):481-4
Genetic Alliance. consumer health - Fibrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prenatal diagnosis of a fibrosarcoma of the thigh: a case report.
  • We report a rare case of fibrosarcoma of the thigh suspected prenatally.
  • At 27 weeks of gestation a voluminous, vascularised mass was discovered at ultrasound on the foetus' left leg, suggestive of haemangioma or a fibrosarcoma.
  • Postnatal ultrasound examination was comparable to that carried out prenatally; pathological examination of the mass biopsied and immunohistochemical investigation provided a diagnosis of congenital fibrosarcoma.
  • [MeSH-major] Fibrosarcoma / ultrasonography. Thigh. Ultrasonography, Prenatal
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Pregnancy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16968999.001).
  • [ISSN] 1015-3837
  • [Journal-full-title] Fetal diagnosis and therapy
  • [ISO-abbreviation] Fetal. Diagn. Ther.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


27. Kaku S, Takeshima N, Akiyama F, Furuta R, Hirai Y, Takizawa K: A unique fibrous tumor of the ovary: fibrosarcoma or mitotically active cellular fibroma? Anticancer Res; 2007 Nov-Dec;27(6C):4365-9
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A unique fibrous tumor of the ovary: fibrosarcoma or mitotically active cellular fibroma?
  • One corresponded to the yellowish lobular areas; there were more than 10 mitotic figures per 10 high-power fields and strong staining for Ki-67, suggesting fibrosarcoma, but nuclear atypia was not severe.
  • Pathologically, the tumor was considered a variant fibrosarcoma or a mitotically active cellular fibroma.
  • [MeSH-major] Fibrosarcoma / pathology. Leiomyoma / pathology. Mitosis. Ovarian Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans. Ki-67 Antigen / metabolism

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18214045.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Ki-67 Antigen
  •  go-up   go-down


28. Li ZJ, Sun P, Guo Y, Wang RZ: Primary pituitary fibrosarcoma presenting with multiple metastases: a case report and literature review. Neurol India; 2010 Mar-Apr;58(2):316-8
MedlinePlus Health Information. consumer health - Pituitary Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary pituitary fibrosarcoma presenting with multiple metastases: a case report and literature review.
  • Even though many cases of pituitary fibrosarcoma (PF) have been reported, the etiologic classification of these tumors, however, remains undefined.
  • Moreover, owing to the paucity of available case studies, the clinical characteristics of primary pituitary fibrosarcoma (PPF) have not been fully described.
  • [MeSH-major] Fibrosarcoma / pathology. Neoplasm Recurrence, Local / secondary. Pituitary Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans. Ki-67 Antigen / metabolism. Magnetic Resonance Imaging / methods. Tumor Suppressor Protein p53 / metabolism

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20508360.001).
  • [ISSN] 0028-3886
  • [Journal-full-title] Neurology India
  • [ISO-abbreviation] Neurol India
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Tumor Suppressor Protein p53
  • [Number-of-references] 13
  •  go-up   go-down


29. Katz P, Colbert R, Drolet B: Unilateral mosaic cutaneous vascular lesions, enchondroma, multiple soft tissue chondromas and congenital fibrosarcoma--a variant of Maffucci syndrome? Pediatr Dermatol; 2008 Mar-Apr;25(2):205-9
Genetic Alliance. consumer health - Maffucci syndrome.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unilateral mosaic cutaneous vascular lesions, enchondroma, multiple soft tissue chondromas and congenital fibrosarcoma--a variant of Maffucci syndrome?
  • Of interest, this patient also has a history of congenital fibrosarcoma with concomitant thrombocytopenia.
  • [MeSH-minor] Adult. Axilla. Biopsy. Dermis / blood supply. Diagnosis, Differential. Fibrosarcoma / congenital. Fibrosarcoma / diagnosis. Humans. Infant, Newborn. Male. Telangiectasis / congenital. Telangiectasis / diagnosis. Vascular Malformations / diagnosis

  • Genetic Alliance. consumer health - Enchondroma.
  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18429781.001).
  • [ISSN] 1525-1470
  • [Journal-full-title] Pediatric dermatology
  • [ISO-abbreviation] Pediatr Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


30. Pontes HA, Pontes FS, Silva BS, Cury SE, Fonseca FP, Salim RA, Pinto Júnior Ddos S: Immunoexpression of Ki67, proliferative cell nuclear antigen, and Bcl-2 proteins in a case of ameloblastic fibrosarcoma. Ann Diagn Pathol; 2010 Dec;14(6):447-52
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunoexpression of Ki67, proliferative cell nuclear antigen, and Bcl-2 proteins in a case of ameloblastic fibrosarcoma.
  • Ameloblastic fibrosarcoma (AFS), regarded as the malignant counterpart of the benign ameloblastic fibroma, is an extremely rare odontogenic neoplasm with only 68 cases reported in the English literature up to 2009.
  • It is composed of a benign odontogenic epithelium, resembling that of ameloblastoma, and a malignant mesenchymal part exhibiting features of fibrosarcoma.
  • [MeSH-major] Fibrosarcoma / metabolism. Ki-67 Antigen / metabolism. Mandibular Neoplasms / metabolism. Odontogenic Tumors / metabolism. Proliferating Cell Nuclear Antigen / metabolism. Proto-Oncogene Proteins c-bcl-2 / metabolism
  • [MeSH-minor] Adult. Ameloblasts / metabolism. Ameloblasts / pathology. Biomarkers, Tumor / metabolism. Combined Modality Therapy. Female. Humans

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 21074695.001).
  • [ISSN] 1532-8198
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Proliferating Cell Nuclear Antigen; 0 / Proto-Oncogene Proteins c-bcl-2
  •  go-up   go-down


31. Scheier M, Ramoni A, Alge A, Brezinka C, Reiter G, Sergi C, Hager J, Marth C: Congenital fibrosarcoma as cause for fetal anemia: prenatal diagnosis and in utero treatment. Fetal Diagn Ther; 2008;24(4):434-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Congenital fibrosarcoma as cause for fetal anemia: prenatal diagnosis and in utero treatment.
  • Histological examination revealed an infantile congenital fibrosarcoma.
  • [MeSH-major] Anemia / etiology. Anemia / therapy. Blood Transfusion, Intrauterine. Fibrosarcoma / complications. Fibrosarcoma / ultrasonography. Soft Tissue Neoplasms / complications. Soft Tissue Neoplasms / ultrasonography
  • [MeSH-minor] Adult. Blood Flow Velocity. Female. Hemorrhage / congenital. Hemorrhage / etiology. Humans. Infant, Newborn. Male. Middle Cerebral Artery / physiology. Pregnancy. Ultrasonography, Prenatal

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • Genetic Alliance. consumer health - Anemia.
  • MedlinePlus Health Information. consumer health - Anemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2008 S. Karger AG, Basel.
  • (PMID = 19018145.001).
  • [ISSN] 1421-9964
  • [Journal-full-title] Fetal diagnosis and therapy
  • [ISO-abbreviation] Fetal. Diagn. Ther.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


32. Leitner C, Hoffmann J, Kröber S, Reinert S: Low-grade malignant fibrosarcoma of the dental follicle of an unerupted third molar without clinical evidence of any follicular lesion. J Craniomaxillofac Surg; 2007 Jan;35(1):48-51
MedlinePlus Health Information. consumer health - Tooth Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade malignant fibrosarcoma of the dental follicle of an unerupted third molar without clinical evidence of any follicular lesion.
  • BACKGROUND: Sarcomas are rarely seen in the head and neck region.
  • PATIENT: This paper reports a 23-year-old female patient who underwent routine surgical removal of unerupted wisdom teeth without clinical evidence of any follicular lesion and was diagnosed with a low-grade malignant fibrosarcoma of the dental follicle of the lower left unerupted third molar.
  • [MeSH-major] Dental Sac / pathology. Fibrosarcoma / diagnosis. Molar, Third / pathology. Tooth Diseases / diagnosis. Tooth, Unerupted / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Neoplasm Staging

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Craniomaxillofac Surg. 2007 Mar;35(2):135 [17448666.001]
  • [CommentIn] J Craniomaxillofac Surg. 2009 Sep;37(6):348 [19038553.001]
  • (PMID = 17296310.001).
  • [ISSN] 1010-5182
  • [Journal-full-title] Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
  • [ISO-abbreviation] J Craniomaxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


33. Chukwuanukwu TO, Anyanwu SN: Giant fibrosarcoma prostuberans of abodominal wall: management problems in resources-constrained country. Niger J Clin Pract; 2009 Sep;12(3):338-40
Genetic Alliance. consumer health - Fibrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant fibrosarcoma prostuberans of abodominal wall: management problems in resources-constrained country.
  • BACKGROUND: Abdominal wall sarcomas represent less than 1% of adult malignancies.
  • METHODS: Prospective study of patients with abdominal wall soft tissue sarcoma presenting to the authors.
  • [MeSH-major] Abdominal Neoplasms / diagnosis. Abdominal Neoplasms / surgery. Abdominal Wall / pathology. Abdominal Wall / surgery. Fibrosarcoma / diagnosis. Fibrosarcoma / surgery
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged. Nigeria. Surgical Mesh

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19803041.001).
  • [ISSN] 1119-3077
  • [Journal-full-title] Nigerian journal of clinical practice
  • [ISO-abbreviation] Niger J Clin Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Nigeria
  •  go-up   go-down


34. Coelho PN, Banazol NG, Soares RJ, Fragata JI: Long-term survival with heart transplantation for fibrosarcoma of the heart. Ann Thorac Surg; 2010 Aug;90(2):635-6
MedlinePlus Health Information. consumer health - Heart Transplantation.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term survival with heart transplantation for fibrosarcoma of the heart.
  • Primary sarcoma of the heart is a rare disease that has an ominous prognosis with either medical or surgical therapy.
  • We report a case of a 25-year-old woman with sarcoma of the heart who received a transplant and is clinically well after 7 years.
  • [MeSH-major] Fibrosarcoma / surgery. Heart Neoplasms / surgery. Heart Transplantation
  • [MeSH-minor] Adult. Female. Humans. Survivors. Time Factors

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • Genetic Alliance. consumer health - Transplantation.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20667366.001).
  • [ISSN] 1552-6259
  • [Journal-full-title] The Annals of thoracic surgery
  • [ISO-abbreviation] Ann. Thorac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


35. Niini T, López-Guerrero JA, Ninomiya S, Guled M, Hattinger CM, Michelacci F, Böhling T, Llombart-Bosch A, Picci P, Serra M, Knuutila S: Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study. Genes Chromosomes Cancer; 2010 Feb;49(2):132-43
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study.
  • Very little is known about the genetics of fibrosarcoma (FS) of bone.
  • [MeSH-major] Bone Neoplasms / genetics. Cyclin-Dependent Kinase Inhibitor p16 / genetics. Fibrosarcoma / genetics. Gene Amplification. Gene Deletion. Proto-Oncogene Proteins c-kit / genetics. Receptor, Platelet-Derived Growth Factor alpha / genetics. Vascular Endothelial Growth Factor Receptor-2 / genetics
  • [MeSH-minor] Adult. Aged. Chromosome Mapping. Chromosomes, Human, Pair 13. Chromosomes, Human, X. Comparative Genomic Hybridization. DNA, Neoplasm / genetics. DNA, Neoplasm / isolation & purification. Female. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19862822.001).
  • [ISSN] 1098-2264
  • [Journal-full-title] Genes, chromosomes & cancer
  • [ISO-abbreviation] Genes Chromosomes Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cyclin-Dependent Kinase Inhibitor p16; 0 / DNA, Neoplasm; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor alpha; EC 2.7.10.1 / Vascular Endothelial Growth Factor Receptor-2
  •  go-up   go-down


36. Huang L, Liao LM, Wang HY, Zheng M: Clinicopathologic characteristics and prognostic factors of ovarian fibrosarcoma: the results of a multi-center retrospective study. BMC Cancer; 2010;10:585
MedlinePlus Health Information. consumer health - Ovarian Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathologic characteristics and prognostic factors of ovarian fibrosarcoma: the results of a multi-center retrospective study.
  • BACKGROUND: Ovarian fibrosarcomas are very rare tumors, and therefore, few case studies have evaluated the prognostic factors of this disease.
  • To our knowledge, this study represents the largest study to evaluate the clinical and pathologic factors associated with ovarian fibrosarcoma patients.
  • METHODS: Thirty-one cases of ovarian fibrosarcoma were retrospectively reviewed, which included medical records for eight patients, and 23 published case reports from 1995 through 2009.
  • CONCLUSIONS: Mitotic activity, and cells positive for Ki-67 were identified as important factors in the diagnosis of ovarian fibrosarcoma.
  • [MeSH-major] Fibrosarcoma / diagnosis. Ovarian Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Cell Proliferation. Cohort Studies. Female. Humans. Ki-67 Antigen / biosynthesis. Middle Aged. Mitosis. Multivariate Analysis. Prognosis. Retrospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Gynecol Cancer. 2001 Jul-Aug;11(4):331-3 [11520377.001]
  • [Cites] Ultrasound Obstet Gynecol. 2009 Jan;33(1):112-5 [19072774.001]
  • [Cites] Gynecol Oncol. 2002 Jan;84(1):150-4 [11748992.001]
  • [Cites] Acta Obstet Gynecol Scand. 2002 Apr;81(4):375-6 [11952474.001]
  • [Cites] Arch Pathol Lab Med. 2003 Jan;127(1):81-4 [12521373.001]
  • [Cites] Pediatr Surg Int. 2003 Nov;19(9-10):683-5 [14579071.001]
  • [Cites] Virchows Arch. 2004 Oct;445(4):410-3 [15322876.001]
  • [Cites] Cancer. 1981 Jun 1;47(11):2663-70 [7260859.001]
  • [Cites] Obstet Gynecol Surv. 1987 Jun;42(6):331-49 [3299172.001]
  • [Cites] Int J Gynecol Pathol. 1985;4(1):83-7 [3880154.001]
  • [Cites] Acta Pathol Jpn. 1990 Nov;40(11):845-50 [1706556.001]
  • [Cites] Obstet Gynecol. 1971 Jun;37(6):920-41 [4378308.001]
  • [Cites] Am J Surg Pathol. 1997 Jan;21(1):52-9 [8990141.001]
  • [Cites] J Clin Pathol. 1998 Nov;51(11):868-71 [10193334.001]
  • [Cites] Int J Gynecol Cancer. 2005 Nov-Dec;15(6):1142-7 [16343198.001]
  • [Cites] Am J Surg Pathol. 2006 Aug;30(8):929-38 [16861962.001]
  • [Cites] J Obstet Gynaecol Res. 2006 Oct;32(5):524-8 [16984523.001]
  • [Cites] Pathol Int. 2001 Sep;51(9):739-43 [11696180.001]
  • (PMID = 20979607.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ki-67 Antigen
  • [Other-IDs] NLM/ PMC2984427
  •  go-up   go-down


37. Irving JA, Alkushi A, Young RH, Clement PB: Cellular fibromas of the ovary: a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma. Am J Surg Pathol; 2006 Aug;30(8):929-38
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cellular fibromas of the ovary: a study of 75 cases including 40 mitotically active tumors emphasizing their distinction from fibrosarcoma.
  • Cellular fibroblastic tumors of the ovary are currently classified as either cellular fibroma (CF) or fibrosarcoma.
  • The former are characterized by bland nuclei, 3 or fewer mitotic figures per 10 high-power fields (MFs/10 HPFs), and a low malignant potential, whereas fibrosarcomas usually have severe nuclear atypia, > or = 4 MFs/10 HPFs, and an aggressive clinical course.
  • It has been our anecdotal experience that otherwise typical CFs with > or = 4 MFs/10 HPFs usually have a benign clinical course, suggesting that such tumors should be regarded as "mitotically active cellular fibroma" (MACF) rather than fibrosarcoma.
  • We conclude that cellular fibromatous neoplasms with bland cytology and elevated mitotic counts are associated with favorable patient outcome and should be diagnosed as MACF rather than fibrosarcoma, which usually have moderate to severe atypia and elevated mitotic rates.
  • [MeSH-major] Fibroma / pathology. Fibrosarcoma / pathology. Ovarian Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Female. Humans. Middle Aged. Mitotic Index. Prognosis

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16861962.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Chiu HW, Lin JH, Chen YA, Ho SY, Wang YJ: Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis. Autophagy; 2010 Apr;6(3):353-65
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis.
  • The traditional treatments for fibrosarcoma have limited efficacy.
  • In the present study, we investigated the anticancer effects of ionizing radiation (IR) combined with arsenic trioxide (ATO) in human fibrosarcoma cells in vitro and in xenograft tumors in SCID mice in vivo.
  • The data suggest that a combination of IR and ATO could be a new potential therapeutic strategy for the treatment of fibrosarcoma.
  • [MeSH-major] Antineoplastic Agents. Apoptosis. Arsenicals. Autophagy. Fibrosarcoma. Oxides
  • [MeSH-minor] Adult. Animals. Cell Cycle / drug effects. Cell Cycle / physiology. Cell Cycle / radiation effects. Cell Line, Tumor. Dose-Response Relationship, Drug. Dose-Response Relationship, Radiation. Gene Expression Regulation, Neoplastic. Humans. Male. Mice. Mice, SCID. Neoplasm Transplantation


39. Huang SY, Wang CW, Wang CJ, Chao A, Chao AS: Combined prenatal ultrasound and magnetic resonance imaging in an extensive congenital fibrosarcoma: a case report and review of the literature. Fetal Diagn Ther; 2005 Jul-Aug;20(4):266-71
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined prenatal ultrasound and magnetic resonance imaging in an extensive congenital fibrosarcoma: a case report and review of the literature.
  • To determine whether the prognosis of congenital (infantile) fibrosarcoma in the retroperitoneum, an extremely rare form of soft tissue malignant tumor, can be assessed prenatally.
  • [MeSH-major] Fetal Diseases / pathology. Fibrosarcoma / pathology. Magnetic Resonance Imaging. Retroperitoneal Neoplasms / pathology. Ultrasonography, Prenatal
  • [MeSH-minor] Adult. Female. Humans. Pregnancy

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • MedlinePlus Health Information. consumer health - Fetal Health and Development.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2005 S. Karger AG, Basel.
  • (PMID = 15980638.001).
  • [ISSN] 1015-3837
  • [Journal-full-title] Fetal diagnosis and therapy
  • [ISO-abbreviation] Fetal. Diagn. Ther.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 10
  •  go-up   go-down


40. Guillou L, Benhattar J, Gengler C, Gallagher G, Ranchère-Vince D, Collin F, Terrier P, Terrier-Lacombe MJ, Leroux A, Marquès B, Aubain Somerhausen Nde S, Keslair F, Pedeutour F, Coindre JM: Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group. Am J Surg Pathol; 2007 Sep;31(9):1387-402
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.
  • Low-grade fibromyxoid sarcomas (LGFMS) bear either the t(7,16) (q32-34;p11) or t(11,16) (p11;p11) translocations, resulting in FUS-CREB3L2 or FUS-CREB3L1 fusions, respectively.
  • Of all, 7/52 non-LGMFS neoplasms contained FUS-CREB3L2 transcripts, of which 4 had been diagnosed as sclerosing epithelioid fibrosarcoma.
  • The presence of epithelioid cells and fusion transcripts in both LGFMS and a subset of sclerosing epithelioid fibrosarcoma suggest that these neoplasms might be related.
  • [MeSH-major] Basic-Leucine Zipper Transcription Factors / genetics. Biomarkers, Tumor / genetics. Cyclic AMP Response Element-Binding Protein / genetics. Epithelioid Cells / pathology. Fibroma / diagnosis. Fibrosarcoma / diagnosis. Gene Expression Regulation, Neoplastic. Nerve Tissue Proteins / genetics. RNA-Binding Protein FUS / genetics. Translocation, Genetic
  • [MeSH-minor] Adolescent. Adult. Aged. Base Sequence. Child. Female. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged. Molecular Sequence Data. Neoplasm Invasiveness. Paraffin Embedding. Predictive Value of Tests. RNA, Messenger / analysis. Reproducibility of Results. Reverse Transcriptase Polymerase Chain Reaction. Sensitivity and Specificity

  • Genetic Alliance. consumer health - Epithelioid Sarcoma.
  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17721195.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Basic-Leucine Zipper Transcription Factors; 0 / Biomarkers, Tumor; 0 / CREB3L1 protein, human; 0 / CREB3L2 protein, human; 0 / Cyclic AMP Response Element-Binding Protein; 0 / Nerve Tissue Proteins; 0 / RNA, Messenger; 0 / RNA-Binding Protein FUS
  •  go-up   go-down


41. Nakamura Y, Inui K, Yoshino J, Tokoro T, Sabater L, Takeda S, Yamashita K, Okochi O, Nakao A: Inflammatory myofibroblastic tumor (inflammatory fibrosarcoma) of the pancreas: a case report. Hepatogastroenterology; 2005 Mar-Apr;52(62):625-8
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inflammatory myofibroblastic tumor (inflammatory fibrosarcoma) of the pancreas: a case report.
  • Inflammatory myofibroblastic tumors (inflammatory fibrosarcomas) of the pancreas are extremely rare.
  • [MeSH-major] Fibroblasts / pathology. Fibrosarcoma / diagnosis. Myocytes, Smooth Muscle / pathology. Pancreatic Neoplasms / diagnosis
  • [MeSH-minor] Adult. Angiography. Female. Humans. Immunohistochemistry. Inflammation / pathology. Radiography, Abdominal. Tomography, X-Ray Computed. Ultrasonography. Vimentin / metabolism

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • Genetic Alliance. consumer health - Inflammatory myofibroblastic tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15816492.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Vimentin
  •  go-up   go-down


42. El Mesbahi O, Arifi S, Benbrahim Z, El Ibrahimi A, Kettani F, Bennani A, Amarti A, Lamrani MY, Tizniti S, El Mrini A: A rare case of locally advanced fibrosarcoma of diaphysal humerus managed successfully with limb-sparing procedures after neoadjuvant chemotherapy. World J Surg Oncol; 2010;8:77
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A rare case of locally advanced fibrosarcoma of diaphysal humerus managed successfully with limb-sparing procedures after neoadjuvant chemotherapy.
  • Fibrosarcomas (FS) of bone are a rare malignancy accounting for less than 5% of all primary malignant bone neoplasms.
  • [MeSH-major] Bone Neoplasms / surgery. Fibrosarcoma / surgery. Humerus
  • [MeSH-minor] Adult. Chemotherapy, Adjuvant. Diaphyses. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Neoadjuvant Therapy. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 2000 Apr;(373):88-103 [10810466.001]
  • [Cites] Cancer. 1975 Mar;35(3):837-47 [1053940.001]
  • [Cites] Cancer. 1995 Jan 1;75(1 Suppl):203-10 [8000997.001]
  • [Cites] Int J Clin Oncol. 2006 Jun;11(3):229-35 [16850130.001]
  • [Cites] Arch Phys Med Rehabil. 1999 Jun;80(6):615-8 [10378484.001]
  • [Cites] Eur J Cell Biol. 2004 Sep;83(9):483-91 [15540465.001]
  • [Cites] Clin Orthop Relat Res. 1999 May;(362):181-9 [10335297.001]
  • (PMID = 20819211.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2945346
  •  go-up   go-down


43. Meissner M, König V, Hrgovic I, Valesky E, Kaufmann R: Human leucocyte antigen class I and class II antigen expression in malignant fibrous histiocytoma, fibrosarcoma and dermatofibrosarcoma protuberans is significantly downregulated. J Eur Acad Dermatol Venereol; 2010 Nov;24(11):1326-32
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Human leucocyte antigen class I and class II antigen expression in malignant fibrous histiocytoma, fibrosarcoma and dermatofibrosarcoma protuberans is significantly downregulated.
  • To date, studies analysing HLA class I and class II expression levels in malignant fibrous histiocytomas, fibrosarcomas and dermatofibrosarcoma protuberans are limited.
  • AIMS: Therefore, we investigated the in vivo expression profile of HLA class I and class II antigens in 99 malignant fibrous histiocytomas, 20 fibrosarcomas and 34 dermatofibrosarcoma protuberans from different anatomical sites.
  • DISCUSSION: The data presented suggest for the first time a high frequency of HLA class I and class II abnormalities in malignant fibrous histiocytomas, fibrosarcomas and dermatofibrosarcoma protuberans in vivo.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Antigen Presentation / immunology. Child. Child, Preschool. Dermatofibrosarcoma / immunology. Dermatofibrosarcoma / metabolism. Dermatofibrosarcoma / pathology. Down-Regulation / immunology. Female. Humans. Immunohistochemistry. Male. Middle Aged. Prognosis. Tumor Escape / immunology. Young Adult

  • Genetic Alliance. consumer health - Dermatofibrosarcoma Protuberans.
  • Genetic Alliance. consumer health - Fibrosarcoma.
  • Genetic Alliance. consumer health - Malignant fibrous histiocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.
  • (PMID = 20337820.001).
  • [ISSN] 1468-3083
  • [Journal-full-title] Journal of the European Academy of Dermatology and Venereology : JEADV
  • [ISO-abbreviation] J Eur Acad Dermatol Venereol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Histocompatibility Antigens Class I; 0 / Histocompatibility Antigens Class II
  •  go-up   go-down


44. Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A, Elwood L, Vaughn DJ, Griffin CA, Epstein JI: Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol; 2006 Dec;30(12):1502-12
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
  • [MeSH-major] Carcinoma, Transitional Cell / pathology. Fibrosarcoma / pathology. Granuloma, Plasma Cell / pathology. Prostate / pathology. Ureter / pathology. Urinary Bladder / pathology. Urologic Diseases / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Child. Child, Preschool. Female. Humans. In Situ Hybridization, Fluorescence. Inflammation / pathology. Male. Middle Aged. Protein-Tyrosine Kinases / genetics. Protein-Tyrosine Kinases / metabolism. Receptor Protein-Tyrosine Kinases. Urothelium / enzymology. Urothelium / pathology

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17122505.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Receptor Protein-Tyrosine Kinases; EC 2.7.10.1 / anaplastic lymphoma kinase
  •  go-up   go-down


45. Lamovec J, Volavsek M: Sclerosing rhabdomyosarcoma of the parotid gland in an adult. Ann Diagn Pathol; 2009 Oct;13(5):334-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sclerosing rhabdomyosarcoma of the parotid gland in an adult.
  • Sclerosing rhabdomyosarcoma may cause differential diagnostic problems because it could be confounded for osteosarcoma, chondrosarcoma, and some other types of sarcoma, and as in our case, for myxofibrosarcoma and myoepithelial carcinoma.
  • Its location in the head and neck is of special interest because 6 of 14 previously described adult cases of sclerosing rhabdomyosarcoma and 7 of 18 pediatric cases also occurred in this region.
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Cell Nucleus / metabolism. Cell Nucleus / pathology. Diagnosis, Differential. Disease-Free Survival. Fibrosarcoma / diagnosis. Humans. Male. Middle Aged. Sclerosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19751910.001).
  • [ISSN] 1532-8198
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / MyoD Protein; 0 / MyoD1 myogenic differentiation protein
  •  go-up   go-down


46. Chen W, Begum S, Opare-Addo L, Garyu J, Gibson TF, Bothwell AL, Papaioannou VE, Herold KC: Promotion of beta-cell differentiation in pancreatic precursor cells by adult islet cells. Endocrinology; 2009 Feb;150(2):570-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Promotion of beta-cell differentiation in pancreatic precursor cells by adult islet cells.
  • In this study, we tested whether adult islet cells can affect the differentiation process in mouse and human pancreatic anlage cells.
  • We assessed beta-cell proliferation and differentiation in mouse and human pancreatic anlage cells cocultured with adult islet cells or betaTC3 cells using cellular, molecular, and immunohistochemical methods.
  • Human pancreatic anlage cells responded in a similar manner and showed increased expression of pancreatic duodenal homeobox 1 and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A and increased production of proinsulin when cocultured with adult islets.
  • [MeSH-minor] Adult. Animals. Antigens, Surface / physiology. Cell Communication / physiology. Cells, Cultured. Coculture Techniques / methods. Green Fluorescent Proteins / genetics. Humans. Mice. Mice, Inbred BALB C. Mice, Inbred NOD. Mice, SCID. Mice, Transgenic

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Invest. 2007 Sep;117(9):2553-61 [17786244.001]
  • [Cites] J Mol Endocrinol. 2000 Jun;24(3):297-302 [10828822.001]
  • [Cites] Stem Cells. 2006 Feb;24(2):258-65 [16109755.001]
  • [Cites] Diabetes. 2001 Feb;50 Suppl 1:S5-9 [11272202.001]
  • [Cites] J Clin Invest. 2007 Jan;117(1):81-3 [17200709.001]
  • [Cites] Transplantation. 2005 May 15;79(9):1091-6 [15880049.001]
  • [Cites] J Cell Sci. 2002 Feb 15;115(Pt 4):753-60 [11865031.001]
  • [Cites] Nature. 2007 Feb 22;445(7130):886-91 [17259975.001]
  • [Cites] Diabetes. 2007 Jul;56(7):1792-801 [17400928.001]
  • [Cites] Nat Med. 2006 Mar;12 (3):310-6 [16491084.001]
  • [Cites] Diabetes. 1995 Mar;44(3):306-13 [7533732.001]
  • [Cites] Endocrinology. 2000 Jun;141(6):1926-9 [10830272.001]
  • [Cites] Transplantation. 2002 Sep 27;74(6):877-9 [12364870.001]
  • [Cites] Mech Dev. 2003 Jan;120(1):35-43 [12490294.001]
  • [Cites] Nat Biotechnol. 2006 Nov;24(11):1392-401 [17053790.001]
  • [Cites] Diabetes. 2005 Oct;54(10):2867-74 [16186387.001]
  • [Cites] Endocrinology. 2000 Jun 1;141(6):1926-1929 [28200925.001]
  • [Cites] Biochem J. 1986 Apr 15;235(2):459-67 [3017307.001]
  • [Cites] BMC Biotechnol. 2004 Dec 24;4:33 [15619330.001]
  • [Cites] Diabetes. 2006 Feb;55(2):269-72 [16361411.001]
  • [Cites] Nature. 1998 Feb 26;391(6670):900-4 [9495343.001]
  • [Cites] Mol Cell Biol. 2005 Jun;25(12):4969-76 [15923615.001]
  • [Cites] J Histochem Cytochem. 2002 Dec;50(12):1625-32 [12486084.001]
  • [Cites] Diabetes. 2003 Mar;52(3):734-40 [12606515.001]
  • [Cites] Nat Biotechnol. 2005 Jul;23(7):857-61 [16003374.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3853-8 [17360442.001]
  • [Cites] Annu Rev Cell Dev Biol. 2003;19:71-89 [14570564.001]
  • [Cites] J Neurosci Res. 2005 May 1;80(3):341-9 [15789407.001]
  • [Cites] Diabetes. 1988 Apr;37(4):413-20 [3288530.001]
  • [Cites] J Pediatr Surg. 1999 May;34(5):689-93; discussion 693-4 [10359165.001]
  • [Cites] Am J Physiol Regul Integr Comp Physiol. 2002 Sep;283(3):R623-30 [12184996.001]
  • [Cites] Nature. 2004 May 6;429(6987):41-6 [15129273.001]
  • [Cites] Genes Dev. 2008 Aug 1;22(15):1998-2021 [18676806.001]
  • [Cites] Diabetes. 1999 May;48(5):989-96 [10331402.001]
  • [Cites] Nat Biotechnol. 2008 Apr;26(4):443-52 [18288110.001]
  • [Cites] Dev Cell. 2006 Mar;10(3):397-405 [16516842.001]
  • [Cites] J Clin Endocrinol Metab. 2002 Oct;87(10):4775-81 [12364473.001]
  • [Cites] Am J Physiol Endocrinol Metab. 2002 Sep;283(3):E413-22 [12169433.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9191-6 [10890921.001]
  • [Cites] J Biol Chem. 2005 Mar 25;280(12):11887-94 [15665000.001]
  • [Cites] Folia Biol (Praha). 2007;53(1):13-22 [17328838.001]
  • [Cites] Diabetes. 2006 Dec;55(12):3238-45 [17130466.001]
  • [Cites] Endocr J. 2008 May;55(2):235-52 [17938503.001]
  • [Cites] J Endocrinol. 2005 Aug;186(2):343-52 [16079260.001]
  • (PMID = 18845629.001).
  • [ISSN] 1945-7170
  • [Journal-full-title] Endocrinology
  • [ISO-abbreviation] Endocrinology
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / R01 DK068661; United States / NIDDK NIH HHS / DK / R01 DK068678
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Surface; 147336-22-9 / Green Fluorescent Proteins
  • [Other-IDs] NLM/ PMC2646532
  •  go-up   go-down


47. de Bree R, van der Waal I, de Bree E, Leemans CR: Management of adult soft tissue sarcomas of the head and neck. Oral Oncol; 2010 Nov;46(11):786-90
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of adult soft tissue sarcomas of the head and neck.
  • Adult soft tissue sarcoma of the head and neck are rare and represent a heterogeneous group of tumours of different histological variants.
  • Malignant fibrous histiocytoma, fibrosarcoma, angiosarcoma and malignant peripheral nerve sheath tumour are the most frequently found sarcoma types in the head and neck.
  • The management of soft tissue sarcomas in the head and neck is primarily surgical.
  • Since it is difficult to obtain wide margins during surgical treatment in head and neck sarcomas, because of anatomic constraints, most patients undergo post-operative irradiation.
  • With further insight into the biology of soft tissue sarcoma, modern imaging techniques and new treatment options, we will most certainly be able to improve clinical outcome in patients with soft tissue sarcoma in the upcoming years.
  • [MeSH-major] Head and Neck Neoplasms / surgery. Sarcoma / surgery. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adult. Female. Humans. Male. Prognosis. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20947413.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  •  go-up   go-down


48. Tateishi U, Hasegawa T, Yamamoto S, Yamaguchi U, Yokoyama R, Kawamoto H, Satake M, Arai Y: Incidence of multiple primary malignancies in a cohort of adult patients with soft tissue sarcoma. Jpn J Clin Oncol; 2005 Aug;35(8):444-52
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence of multiple primary malignancies in a cohort of adult patients with soft tissue sarcoma.
  • OBJECTIVE: Some studies to date have suggested the development of multiple primary malignancies in patients with soft tissue sarcoma.
  • The current study was performed to quantify the risk of development of multiple primary malignancies in adult patients with soft tissue sarcoma.
  • METHODS: A total of 406 consecutive patients who were diagnosed with soft tissue sarcoma were identified in the study analysis.
  • RESULTS: A total of 35 patients with soft tissue sarcoma (9%), having preceding (n = 15) and subsequent (n = 20) malignancies other than soft tissue sarcoma were documented.
  • [MeSH-major] Neoplasms, Second Primary / epidemiology. Sarcoma. Soft Tissue Neoplasms
  • [MeSH-minor] Adult. Aged. Bone Neoplasms / epidemiology. Breast Neoplasms / epidemiology. Cohort Studies. Confounding Factors (Epidemiology). Female. Fibrosarcoma / therapy. Humans. Incidence. Lung Neoplasms / epidemiology. Male. Middle Aged. Multivariate Analysis. Osteosarcoma / epidemiology. Prognosis. Proportional Hazards Models. Prostatic Neoplasms / epidemiology. ROC Curve. Risk

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16024533.001).
  • [ISSN] 0368-2811
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


49. Fodor A, Harel C, Fodor L, Armoni M, Salmon P, Trono D, Karnieli E: Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach. Diabetologia; 2007 Jan;50(1):121-30
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach.
  • AIMS/HYPOTHESIS: We examined a clinical model of ex vivo transdifferentiation of primary adult hepatocytes to insulin-secreting cells for the treatment of type 1 diabetes.
  • The PDX1-transduced hepatocytes expressed several pancreatic transcription factors related to early pancreatic endocrine development (endogenous Pdx1, neurogenic differentiation factor 1 [Neurod1], and NK6 transcription factor related, locus 1 [Nkx6-1]) as well as the late-stage pancreatic transcription factors (paired box gene 4 [Pax4], paired box gene 6 [Pax6], and v-maf musculoaponeurotic fibrosarcoma oncogene homolog A [Mafa]).
  • CONCLUSIONS/INTERPRETATION: Ex vivo lentiviral-mediated PDX1 expression in isolated adult liver cells represents a potential model for type 1 diabetes mellitus therapy.

  • Genetic Alliance. consumer health - Diabetes.
  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • Hazardous Substances Data Bank. STREPTOZOTOCIN .
  • Hazardous Substances Data Bank. GLUCOSE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2000 Aug 25;275(34):26050-7 [10862612.001]
  • [Cites] Mol Endocrinol. 2001 Mar;15(3):476-83 [11222748.001]
  • [Cites] Genes Dev. 1998 Jun 15;12(12):1763-8 [9637677.001]
  • [Cites] Proc Natl Acad Sci U S A. 2000 Jul 5;97(14):7999-8004 [10884429.001]
  • [Cites] Science. 2003 Jan 17;299(5605):363 [12532008.001]
  • [Cites] Diabetes. 2004 Dec;53(12):3168-78 [15561947.001]
  • [Cites] Biochem J. 1995 Sep 15;310 ( Pt 3):997-1003 [7575438.001]
  • [Cites] Development. 1996 Mar;122(3):983-95 [8631275.001]
  • [Cites] Mol Ther. 2001 Apr;3(4):584-90 [11319921.001]
  • [Cites] Science. 2001 May 18;292(5520):1389-94 [11326082.001]
  • [Cites] Gene Ther. 2000 Oct;7(20):1744-52 [11083496.001]
  • [Cites] Gene Ther. 1998 Jul;5(7):888-95 [9813659.001]
  • [Cites] Diabetologia. 2003 Jun;46(6):810-21 [12783165.001]
  • [Cites] Blood. 2000 Nov 15;96(10):3392-8 [11071633.001]
  • [Cites] Diabetes. 1996 Nov;45(11):1478-88 [8866550.001]
  • [Cites] Biochem Biophys Res Commun. 2003 Oct 24;310(3):1017-25 [14550306.001]
  • [Cites] Diabetes. 2001 Aug;50(8):1691-7 [11473026.001]
  • [Cites] J Bone Miner Res. 2002 Jun;17(6):1034-43 [12054158.001]
  • [Cites] Nat Med. 2000 Mar;6(3):278-82 [10700229.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 May 31;102(22):7964-9 [15899968.001]
  • [Cites] Mol Endocrinol. 1996 Nov;10(11):1327-34 [8923459.001]
  • [Cites] Nat Med. 2000 May;6(5):568-72 [10802714.001]
  • [Cites] Biotechnol Prog. 1991 May-Jun;7(3):237-45 [1367596.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7253-8 [12756298.001]
  • [Cites] Nat Med. 2003 May;9(5):596-603 [12704384.001]
  • [Cites] J Biol Chem. 2004 Jul 23;279(30):31121-30 [15151993.001]
  • [Cites] Diabetologia. 2005 Oct;48(10):2051-61 [16132961.001]
  • [Cites] Nat Genet. 1997 Jan;15(1):106-10 [8988180.001]
  • [Cites] EMBO J. 1993 Nov;12(11):4251-9 [7901001.001]
  • [Cites] Science. 1996 Apr 12;272(5259):263-7 [8602510.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11400-6 [8876147.001]
  • [Cites] Transplantation. 2002 Dec 27;74(12):1781-7 [12499898.001]
  • [Cites] Hum Gene Ther. 1997 Jul 1;8(10):1195-206 [9215737.001]
  • [Cites] J Biol Chem. 1990 Jun 25;265(18):10173-6 [2191945.001]
  • [Cites] J Biol Chem. 2002 Mar 29;277(13):11225-32 [11781323.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8078-83 [12048252.001]
  • [Cites] Curr Biol. 2003 Jan 21;13(2):105-15 [12546783.001]
  • [Cites] J Virol. 1998 Nov;72(11):8463-71 [9765382.001]
  • [Cites] Hum Gene Ther. 2002 Jan 20;13(2):243-60 [11812281.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Jun 4;318(3):625-30 [15144883.001]
  • [Cites] Mol Ther. 2002 Aug;6(2):199-209 [12161186.001]
  • [Cites] Diabetes. 2000 Feb;49(2):157-62 [10868930.001]
  • [Cites] Nature. 1994 Oct 13;371(6498):606-9 [7935793.001]
  • [Cites] In Vitro Cell Dev Biol. 1986 Apr;22(4):201-11 [2871008.001]
  • [Cites] J Biol Chem. 2003 Aug 22;278(34):31950-7 [12775714.001]
  • [Cites] Methods Cell Biol. 1976;13:29-83 [177845.001]
  • (PMID = 17131142.001).
  • [ISSN] 0012-186X
  • [Journal-full-title] Diabetologia
  • [ISO-abbreviation] Diabetologia
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Homeodomain Proteins; 0 / Insulin; 0 / Trans-Activators; 0 / pancreatic and duodenal homeobox 1 protein; 5W494URQ81 / Streptozocin; IY9XDZ35W2 / Glucose
  •  go-up   go-down


50. Ozkan B, Ozgüroğlu M, Ozkara H, Durak H, Talat Z: Adult paratesticular myxofibrosarcoma: report of a rare entity and review of the literature. Int Urol Nephrol; 2006;38(1):5-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adult paratesticular myxofibrosarcoma: report of a rare entity and review of the literature.
  • [MeSH-major] Fibrosarcoma / pathology. Genital Neoplasms, Male / pathology. Scrotum

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Urol. 1992 Apr;147(4):1032-6; discussion 1036-7 [1552580.001]
  • [Cites] Am J Surg Pathol. 1996 Apr;20(4):391-405 [8604805.001]
  • [Cites] Acta Pathol Microbiol Immunol Scand Suppl. 1983;282:1-40 [6444190.001]
  • [Cites] Am J Surg Pathol. 1986;10 Suppl 1:14-25 [3296798.001]
  • [Cites] Urology. 2002 Feb;59(2):294-5 [11834406.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1977 Mar;85A(2):127-40 [15396.001]
  • [Cites] Cancer. 1977 Apr;39(4):1672-85 [192434.001]
  • (PMID = 16502045.001).
  • [ISSN] 0301-1623
  • [Journal-full-title] International urology and nephrology
  • [ISO-abbreviation] Int Urol Nephrol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 7
  •  go-up   go-down


51. Matsuyama A, Hisaoka M, Shimajiri S, Hayashi T, Imamura T, Ishida T, Fukunaga M, Fukuhara T, Minato H, Nakajima T, Yonezawa S, Kuroda M, Yamasaki F, Toyoshima S, Hashimoto H: Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens. Am J Surg Pathol; 2006 Sep;30(9):1077-84
Hazardous Substances Data Bank. FORMALDEHYDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
  • A diagnosis of low-grade fibromyxoid sarcoma (LGFMS) remains problematic because of its bland-looking histologic features that can be potentially confused with other benign or low-grade fibromyxoid lesions.
  • The FUS-CREB3L2 fusion transcripts were not detected in any of the 123 other soft-tissue tumors, including desmoid-type fibromatoses, myxofibrosarcomas, soft-tissue perineuriomas, and congenital or adult fibrosarcomas.
  • [MeSH-major] Cyclic AMP Response Element-Binding Protein / genetics. Fibrosarcoma / genetics. Nerve Tissue Proteins / genetics. Oncogene Proteins, Fusion / genetics. Soft Tissue Neoplasms / genetics. Transcription, Genetic
  • [MeSH-minor] Adolescent. Adult. Female. Formaldehyde. Histological Techniques. Humans. Male. Middle Aged. Paraffin. Reverse Transcriptase Polymerase Chain Reaction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16931951.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CREB3L1 protein, human; 0 / Cyclic AMP Response Element-Binding Protein; 0 / Nerve Tissue Proteins; 0 / Oncogene Proteins, Fusion; 1HG84L3525 / Formaldehyde; 8002-74-2 / Paraffin
  •  go-up   go-down


52. Nistor C, Davidescu M, Rus O, Marinescu B, Stefănescu I, Tudose A, Horvat T: Giant laterocervical fibrosarcom. J Med Life; 2009 Jul-Sep;2(3):262-5
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Soft tissue sarcomas are rare tumors representing 1% of all malignancies and less than 10% concerning head and neck tumors.
  • Histopathological examination revealed an intermediate-grade fibrosarcoma.
  • [MeSH-major] Fibrosarcoma / pathology. Fibrosarcoma / surgery. Head and Neck Neoplasms / pathology. Head and Neck Neoplasms / surgery. Soft Tissue Neoplasms / pathology. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adult. Humans. Male. Skin Transplantation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20112469.001).
  • [ISSN] 1844-122X
  • [Journal-full-title] Journal of medicine and life
  • [ISO-abbreviation] J Med Life
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


53. Kim SY, Kim MY, Hwang YJ, Han YH, Seo JW, Kim YH, Cha SJ, Hur G: Low-grade fibromyxoid sarcoma: CT, sonography, and MR findings in 3 cases. J Thorac Imaging; 2005 Nov;20(4):294-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade fibromyxoid sarcoma: CT, sonography, and MR findings in 3 cases.
  • Low-grade fibromyxoid sarcoma (LGFMS) is a distinctive variant of fibrosarcoma characterized by deceptively bland histologic features and a paradoxically aggressive clinical course.
  • [MeSH-major] Fibrosarcoma / diagnosis. Pleural Neoplasms / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adult. Aged. Axilla. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Male. Thoracic Wall. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16282909.001).
  • [ISSN] 0883-5993
  • [Journal-full-title] Journal of thoracic imaging
  • [ISO-abbreviation] J Thorac Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


54. Takahama A Jr, León JE, de Almeida OP, Kowalski LP: Nonlymphoid mesenchymal tumors of the parotid gland. Oral Oncol; 2008 Oct;44(10):970-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Four malignant tumors were classified as rhabdomyosarcoma, fibrosarcoma, Langerhans cell histiocytosis and endodermal sinus tumor.
  • From the malignant cases, only the patient with fibrosarcoma died due the tumor, the other three are alive with no signs of recurrence.
  • All cases were treated by surgery with no recurrences, except one case of fibrosarcoma whose patient died of distant metastasis.
  • [MeSH-minor] Adolescent. Adult. Aged. Brazil. Child. Child, Preschool. Diagnosis, Differential. Endodermal Sinus Tumor / pathology. Female. Fibrosarcoma / pathology. Histiocytosis, Langerhans-Cell / pathology. Humans. Infant. Male. Middle Aged. Neurofibroma / pathology. Rhabdomyosarcoma / pathology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18282791.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


55. Gleizal A, Ranchere-Vince C, Beziat JL: Inflammatory myofibroblastic tumour of the tongue: a case report. Br J Oral Maxillofac Surg; 2007 Jul;45(5):423-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A 22-year-old white woman presented with a recurrent mass in her tongue that had originally been diagnosed as a fibrosarcoma.
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Fibrosarcoma / diagnosis. Humans. Immunohistochemistry

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16510218.001).
  • [ISSN] 0266-4356
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


56. Gleizal A, Ranchere-Vince D, Abou-Chebel N, Nimeskern N, Béziat JL: [Inflammatory myofibroblastic pseudotumor of the tongue]. Rev Stomatol Chir Maxillofac; 2005 Nov;106(5):304-7
MedlinePlus Health Information. consumer health - Tongue Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • After a first diagnosis of fibrosarcoma, a new examination of the slide and immunohistochemical examination led to the definitive diagnosis of inflammatory myofibroblastic tumor of the tongue and not fibrosarcoma.
  • [MeSH-minor] Actins / analysis. Adult. Diagnosis, Differential. Female. Fibrosarcoma / diagnosis. Humans. Immunohistochemistry. Vimentin / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16292226.001).
  • [ISSN] 0035-1768
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Actins; 0 / Vimentin
  •  go-up   go-down


57. Riechelmann H, Meling D, Messer P, Richter HP, Rettinger G, Antoniadis G: [Subcranial resection of malignant tumors infiltrating the anterior skull base]. Laryngorhinootologie; 2006 Jun;85(6):426-34

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fifteen patients suffered from advanced carcinoma, 3 from advanced esthesioneuroblastoma, and 1 patient had a fibrosarcoma.
  • [MeSH-major] Carcinoma / surgery. Cranial Fossa, Anterior / surgery. Esthesioneuroblastoma, Olfactory / surgery. Fibrosarcoma / surgery. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adenocarcinoma / mortality. Adenocarcinoma / pathology. Adenocarcinoma / surgery. Adult. Aged. Carcinoma, Squamous Cell / mortality. Carcinoma, Squamous Cell / pathology. Carcinoma, Squamous Cell / surgery. Carcinoma, Transitional Cell / mortality. Carcinoma, Transitional Cell / pathology. Carcinoma, Transitional Cell / surgery. Chemotherapy, Adjuvant. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Invasiveness. Postoperative Complications / mortality. Probability. Quality of Life. Radiotherapy, Adjuvant. Retrospective Studies. Survival Rate

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16586282.001).
  • [ISSN] 0935-8943
  • [Journal-full-title] Laryngo- rhino- otologie
  • [ISO-abbreviation] Laryngorhinootologie
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


58. Virgintino D, Errede M, Girolamo F, Capobianco C, Robertson D, Vimercati A, Serio G, Di Benedetto A, Yonekawa Y, Frei K, Roncali L: Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J Neuropathol Exp Neurol; 2008 Jan;67(1):50-61
Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To establish an immunohistochemical procedure for P-gp detection, different anti-P-gp monoclonal antibodies were first tested on a fibrosarcoma cell line and colonic carcinoma tissue.
  • The protocol was then tested on adult human brains as a BBB-P-gp tissue-specific control and for double labeling with anti-P-gp and the astroglia marker glial fibrillary acidic protein (GFAP).
  • [MeSH-minor] Adult. Age Factors. Carcinoma / metabolism. Caveolins / metabolism. Cell Line, Tumor. Colonic Neoplasms / metabolism. Female. Fetus. Fibrosarcoma / metabolism. Glial Fibrillary Acidic Protein / metabolism. Humans. Male. Middle Aged. Vimentin / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18091560.001).
  • [ISSN] 0022-3069
  • [Journal-full-title] Journal of neuropathology and experimental neurology
  • [ISO-abbreviation] J. Neuropathol. Exp. Neurol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Caveolins; 0 / Glial Fibrillary Acidic Protein; 0 / P-Glycoprotein; 0 / Vimentin
  •  go-up   go-down


59. Kakuta Y, Kobayashi Y, Katoh T, Saitoh J, Yazawa K, Hosomi M, Itoh K: [Three cases of retroperitoneal soft tissue sarcoma]. Hinyokika Kiyo; 2006 Apr;52(4):271-5
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Three cases of retroperitoneal soft tissue sarcoma].
  • Soft tissue sarcomas (STS) are rare tumors that comprise only 1% of all malignancies.
  • Histologically, it was fibrosarcoma 3,000 g in weight.
  • It was undifferentiated sarcoma 2,000 g in weight.
  • [MeSH-major] Retroperitoneal Neoplasms / radiography. Sarcoma / radiography. Soft Tissue Neoplasms / radiography
  • [MeSH-minor] Adult. Aged. Female. Fibrosarcoma / radiography. Fibrosarcoma / surgery. Humans. Liposarcoma / radiography. Liposarcoma / surgery. Male. Prognosis. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16686354.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


60. Sopta J, Dordević A, Tulić G, Mijucić V: Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases. J Cancer Res Clin Oncol; 2008 Feb;134(2):147-52
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Classification of the high-grade components was based on the immunohistochemical analyses, which evidenced MFH in 18 cases, osteosarcoma in 4, while fibrosarcoma was evidenced in 2 and rhabdomyosarcoma in 1 case.
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / metabolism. Female. Fibrosarcoma / diagnostic imaging. Fibrosarcoma / pathology. Fibrosarcoma / surgery. Humans. Immunoenzyme Techniques. Male. Middle Aged. Osteosarcoma / diagnostic imaging. Osteosarcoma / pathology. Osteosarcoma / surgery. Prognosis. Radiography. Rhabdomyosarcoma / diagnostic imaging. Rhabdomyosarcoma / pathology. Rhabdomyosarcoma / surgery

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Am. 2001 Nov;83-A(11):1630-42 [11701784.001]
  • [Cites] Cancer. 2006 Jun 15;106(12 ):2682-91 [16691621.001]
  • [Cites] Lancet Oncol. 2005 Aug;6(8):599-607 [16054571.001]
  • [Cites] Virchows Arch. 2002 Sep;441(3):219-30 [12242518.001]
  • [Cites] Folia Morphol (Warsz). 2003 Nov;62(4):513-5 [14655155.001]
  • [Cites] Mod Pathol. 2001 Apr;14(4):343-9 [11301351.001]
  • [Cites] Pathol Res Pract. 2003;199(6):437-44 [12924447.001]
  • [Cites] J Cancer Res Clin Oncol. 2005 Jun;131(6):333-9 [15785935.001]
  • [Cites] J Bone Joint Surg Am. 2004 Nov;86-A(11):2412-8 [15523011.001]
  • [Cites] Clin Radiol. 2004 Mar;59(3):268-72 [15037140.001]
  • [Cites] Cesk Patol. 2003 Apr;39(2):59-63 [12874902.001]
  • [Cites] Cancer Genet Cytogenet. 2003 Jul 1;144(1):61-4 [12810257.001]
  • [Cites] Ann Diagn Pathol. 2002 Jun;6(3):159-63 [12089726.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Mar;97(3):369-75 [15024362.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1987;411(1):23-32 [2437690.001]
  • (PMID = 17653766.001).
  • [ISSN] 1432-1335
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


61. Grivas A, Trafalis DT, Thanopoulou E, Ziras NG, Athanasiou AE: Treatment with trabectedin: should be indicated to all soft tissue sarcoma histotypes? J BUON; 2010 Oct-Dec;15(4):791-3
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment with trabectedin: should be indicated to all soft tissue sarcoma histotypes?
  • Trabectedin is a novel antineoplastic agent approved as monotherapy in patients with advanced soft tissue sarcoma (STS) after failure of standard therapy with anthracyclines or ifosfamide, or patients who are unsuited to receive these agents.
  • We report on two patients suffering from infrequent subtypes of STSs, fibrosarcoma and epithelioid sarcoma, who were treated with trabectedin.
  • [MeSH-major] Antineoplastic Agents, Alkylating / adverse effects. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Dioxoles / adverse effects. Fibrosarcoma / drug therapy. Sarcoma / drug therapy. Tetrahydroisoquinolines / adverse effects
  • [MeSH-minor] Adult. Female. Humans. Lung Neoplasms / chemically induced. Lung Neoplasms / secondary. Male. Prognosis

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21229647.001).
  • [ISSN] 1107-0625
  • [Journal-full-title] Journal of B.U.ON. : official journal of the Balkan Union of Oncology
  • [ISO-abbreviation] J BUON
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Dioxoles; 0 / Tetrahydroisoquinolines; 114899-77-3 / trabectedin
  •  go-up   go-down


62. Huang HY, Brennan MF, Singer S, Antonescu CR: Distant metastasis in retroperitoneal dedifferentiated liposarcoma is rare and rapidly fatal: a clinicopathological study with emphasis on the low-grade myxofibrosarcoma-like pattern as an early sign of dedifferentiation. Mod Pathol; 2005 Jul;18(7):976-84
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The metastatic incidence of retroperitoneal dedifferentiated liposarcoma is comparatively lower than other pleomorphic sarcomas, varying widely from 1 to 18%.
  • Low-grade dedifferentiation resembling low-grade fibrosarcoma has been recently accepted as part of the morphologic spectrum of dedifferentiated liposarcoma and was reported to have similar metastatic and survival rates to its high-grade counterpart.
  • [MeSH-minor] Adult. Aged. Cell Differentiation. Female. Fibrosarcoma / pathology. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Metastasis. Time Factors

  • Genetic Alliance. consumer health - Liposarcoma.
  • Genetic Alliance. consumer health - Retroperitoneal liposarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15832195.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


63. Collini P, Sorensen PH, Patel S, Blay JY, Issels RD, Maki RG, Eriksson M, del Muro XG: Sarcomas with spindle cell morphology. Semin Oncol; 2009 Aug;36(4):324-37
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sarcomas with spindle cell morphology.
  • In the days before the term "high-grade undifferentiated pleomorphic sarcoma" came into use, one of the most common sarcoma diagnoses was "malignant fibrous histiocytoma," and before that, in an era before immunohistochemistry, "fibrosarcoma" was used to describe most sarcomas.
  • "Spindle cell" is a descriptive phrase that denotes the cellular shape of many of the sarcomas encountered in the adult population.
  • As a result, they are usually treated differently from small round cell sarcomas, and have different biological characteristics than those tumors and sarcomas with epithelioid morphology.
  • As a very broad generalization, sarcomas with a spindle cell microscopic morphology occur in adults and are treated primarily with surgery and often adjuvant or neoadjuvant radiation as primary therapy.
  • In comparison to small round cell sarcomas such as Ewing sarcoma, the use of adjuvant chemotherapy remains controversial, and the sensitivity of these tumors to chemotherapy in the metastatic setting is highly variable.
  • In this article, we describe some of the clinical and biological characteristics of this group of sarcomas.
  • [MeSH-major] Sarcoma / pathology
  • [MeSH-minor] Chemotherapy, Adjuvant. Fibrosarcoma / genetics. Fibrosarcoma / pathology. Gene Fusion. Heat-Shock Response. Humans. Hyperthermia, Induced. Protein Kinase Inhibitors / therapeutic use. Sarcoma, Synovial / genetics. Sarcoma, Synovial / pathology. Translocation, Genetic

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19664493.001).
  • [ISSN] 0093-7754
  • [Journal-full-title] Seminars in oncology
  • [ISO-abbreviation] Semin. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA47179
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protein Kinase Inhibitors
  • [Number-of-references] 62
  •  go-up   go-down


64. Bifulco K, De Chiara A, Fazioli F, Longanesi-Cattani I, Cantelmo AR, Tirino V, Apice G, Rocco G, Lombardi ML, Carriero MV: Cell invasiveness in sarcomas: a possibly useful clinical correlation. Tumori; 2008 Jul-Aug;94(4):505-10
MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cell invasiveness in sarcomas: a possibly useful clinical correlation.
  • AIMS AND BACKGROUND: The prognosis of each individual patient affected by sarcoma, including those with low histopathologic grading, cannot be reliably predicted at the time of surgery.
  • We have developed an in vitro cell invasion assay on early primary cell cultures derived from surgically removed sarcomas.
  • For each primary cell culture, the sarcoma cell invasion index was determined in comparison with the percentage of human fibrosarcoma HT1080 cell invasion extent.
  • The cell invasion index of 7 different sarcomas was evaluated in respect to the outcome of the disease, after a follow-up ranging from 14 to 48 months.
  • CONCLUSIONS: Our data support the possibility that cell invasion assays performed in vitro on cells derived from human sarcomas may be predictive of a more aggressive form of the disease.
  • [MeSH-major] Sarcoma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Chondrosarcoma / pathology. Collagen. Disease Progression. Disease-Free Survival. Drug Combinations. Female. Fibroma / pathology. Fibrosarcoma / pathology. Humans. Immunohistochemistry. Laminin. Liposarcoma, Myxoid / pathology. Male. Middle Aged. Neoplasm Invasiveness. Predictive Value of Tests. Prognosis. Proteoglycans. Tumor Cells, Cultured

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18822686.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Drug Combinations; 0 / Laminin; 0 / Proteoglycans; 119978-18-6 / matrigel; 9007-34-5 / Collagen
  •  go-up   go-down


65. Perez EA, Gutierrez JC, Moffat FL Jr, Franceschi D, Livingstone AS, Spector SA, Levi JU, Sleeman D, Koniaris LG: Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol; 2007 Mar;14(3):1114-22
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
  • BACKGROUND: Prognostication of truncal and retroperitoneal soft tissue sarcomas has traditionally been predicated on tumor location and grade.
  • OBJECTIVE: To compare outcomes for patients with retroperitoneal or truncal sarcomas.
  • Liposarcoma and fibrosarcoma were associated with improved survival (P < 0.0001).
  • CONCLUSIONS: Successful operative resection can confer prolonged disease-free survival and cure for truncal and retroperitoneal sarcomas.
  • Future studies should focus on histological subtype rather than tumor location for truncal and retroperitoneal sarcomas.
  • [MeSH-major] Retroperitoneal Neoplasms / pathology. Sarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Extremities / pathology. Female. Fibrosarcoma / drug therapy. Fibrosarcoma / pathology. Fibrosarcoma / surgery. Histiocytoma, Benign Fibrous / drug therapy. Histiocytoma, Benign Fibrous / pathology. Histiocytoma, Benign Fibrous / surgery. Humans. Leiomyosarcoma / drug therapy. Leiomyosarcoma / pathology. Leiomyosarcoma / surgery. Liposarcoma / drug therapy. Liposarcoma / pathology. Liposarcoma / surgery. Male. Middle Aged. Prognosis. Retrospective Studies. Risk Factors. Survival Rate. Time Factors

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17206483.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


66. Rodriguez FJ, Scheithauer BW, Perry A, Oliveira AM, Jenkins RB, Oviedo A, Mork SJ, Palmer CA, Burger PC: Ependymal tumors with sarcomatous change ("ependymosarcoma"): a clinicopathologic and molecular cytogenetic study. Am J Surg Pathol; 2008 May;32(5):699-709
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The sarcomatous component consisted of a reticulin rich, glial fibrillary acidic protein-negative fibrosarcoma (n=5) or pleomorphic spindle cell sarcoma (n=3), and 2 examples with heterologous elements: osseous and cartilaginous (n=1) and osseous only (n=1).
  • The single case involving the fourth ventricle/left cerebellopontine angle consisted of subependymoma and fibrosarcoma components in roughly equal proportions at presentation.
  • [MeSH-major] Brain Neoplasms / pathology. Ependymoma / secondary. Fibrosarcoma / secondary
  • [MeSH-minor] Adolescent. Adult. Child. Child, Preschool. Chromosome Aberrations. Combined Modality Therapy. DNA, Neoplasm / analysis. Female. Gene Amplification. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged. Survival Rate

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18347506.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  •  go-up   go-down


67. Hu XP, Xu JP, Liu NN: Primary pulmonary artery sarcoma: surgical management and differential diagnosis with pulmonary embolism and pulmonary valve stenosis. J Card Surg; 2009 Nov-Dec;24(6):613-6
MedlinePlus Health Information. consumer health - Pulmonary Embolism.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary pulmonary artery sarcoma: surgical management and differential diagnosis with pulmonary embolism and pulmonary valve stenosis.
  • BACKGROUND AND AIM OF THE STUDY: Primary pulmonary artery sarcomas are rare and lethal tumors that are usually diagnosed during surgery or autopsy.
  • We present six cases of primary pulmonary artery sarcomas and discuss clinical features, differential diagnosis, surgical treatment, and outcome of the tumors.
  • RESULTS: Histological examinations showed five malignant mesenchymomas and one fibrosarcoma.
  • CONCLUSIONS: Because of similar clinical features, pulmonary artery sarcomas are often confused with other pulmonary vascular obstructive diseases.
  • [MeSH-major] Fibrosarcoma / diagnosis. Fibrosarcoma / surgery. Mesenchymoma / surgery. Pulmonary Artery / surgery. Pulmonary Embolism / diagnosis. Pulmonary Valve Stenosis / diagnosis. Vascular Neoplasms / diagnosis. Vascular Neoplasms / surgery
  • [MeSH-minor] Adult. Cardiopulmonary Bypass. Disease Progression. Early Diagnosis. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Reoperation. Sensitivity and Specificity. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Embolism.
  • Genetic Alliance. consumer health - Pulmonary valve stenosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19549039.001).
  • [ISSN] 1540-8191
  • [Journal-full-title] Journal of cardiac surgery
  • [ISO-abbreviation] J Card Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Tsiatis AC, Atkinson JB, Wright JK, Cates JM: Primary hepatic myxoid leiomyosarcoma: a case report and review of the literature. Ultrastruct Pathol; 2008 Jan-Feb;32(1):25-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sarcomas of the adult liver are unusual neoplasms, and can sometimes pose a difficult differential diagnosis.
  • [MeSH-minor] Actins / analysis. Adult. Biomarkers, Tumor / analysis. Diagnosis, Differential. Female. Fibrosarcoma / diagnosis. Hepatectomy. Humans. Neoplasms, Germ Cell and Embryonal / diagnosis

  • Genetic Alliance. consumer health - Leiomyosarcoma.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18300035.001).
  • [ISSN] 1521-0758
  • [Journal-full-title] Ultrastructural pathology
  • [ISO-abbreviation] Ultrastruct Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Actins; 0 / Biomarkers, Tumor
  •  go-up   go-down


69. Kohashi K, Oda Y, Yamamoto H, Tamiya S, Matono H, Iwamoto Y, Taguchi T, Tsuneyoshi M: Reduced expression of SMARCB1/INI1 protein in synovial sarcoma. Mod Pathol; 2010 Jul;23(7):981-90
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reduced expression of SMARCB1/INI1 protein in synovial sarcoma.
  • Synovial sarcoma is classified as a tumor of uncertain differentiation, and some synovial sarcomas have rhabdoid cells.
  • In previous studies, all malignant rhabdoid tumors and renal medullary carcinomas, some extraskeletal myxoid chondrosarcomas, almost all epithelioid sarcomas and half of epithelioid malignant peripheral nerve sheath tumors showed a loss of SMARCB1/INI1 protein expression in tumor cells and all of these tumors are also known to have rhabdoid cells.
  • We analyzed the immunohistochemical and mRNA expression of SMARCB1/INI1 in 95 synovial sarcomas (73 monophasic fibrous type, 18 biphasic type and 4 poorly differentiated type) and 30 spindle cell sarcomas (3 adult fibrosarcomas, 7 fibrosarcomas arising in dermatofibrosarcoma protuberans, 10 leiomyosarcomas and 10 malignant peripheral nerve sheath tumors) resembling monophasic fibrous synovial sarcoma.
  • The results have shown that 66 of the 95 synovial sarcoma cases (69%) had reduced SMARCB1/INI1 protein expression, whereas the remaining 29 cases (31%) and all 30 spindle cell sarcomas showed preserved this protein expression.
  • The median values of SMARCB1/INI1 mRNA expression in non-tumor skeletal muscle and synovial sarcoma with reduced protein expression were 12.86 and 134.01, respectively, and a statistically significant difference was detected between these two groups (P=0.0000004).
  • However, there was no statistically significant difference of prognosis between the synovial sarcoma group with reduced and that with preserved SMARCB1/INI1 protein expression (P=0.46).
  • Therefore, it was suggested that there is a post-transcriptional SMARCB1/INI1 regulatory mechanism in the tumor cells of synovial sarcoma.
  • [MeSH-major] Chromosomal Proteins, Non-Histone / biosynthesis. DNA-Binding Proteins / biosynthesis. Sarcoma, Synovial / metabolism. Sarcoma, Synovial / pathology. Soft Tissue Neoplasms / metabolism. Soft Tissue Neoplasms / pathology. Transcription Factors / biosynthesis

  • Genetic Alliance. consumer health - Synovial sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20305614.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Chromosomal Proteins, Non-Histone; 0 / DNA-Binding Proteins; 0 / RNA, Messenger; 0 / SMARCB1 protein, human; 0 / Transcription Factors
  •  go-up   go-down


70. Mine T, Matsueda S, Gao H, Li Y, Wong KK, Peoples GE, Ferrone S, Ioannides CG: Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells. Oncol Rep; 2010 Jun;23(6):1537-43
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Notch and Hedgehog activate cell-cycle progression of adult and cancer stem cells.
  • Expansion of CD44 High inversely correlated with Jag-1 density on activating autologous tumor and fibrosarcoma cells.
  • [MeSH-major] Antigens, CD44 / metabolism. Drug Resistance, Neoplasm. Fibrosarcoma / metabolism. Ovarian Neoplasms / metabolism. Paclitaxel / pharmacology. RNA, Small Interfering / genetics. Transcription Factors / genetics

  • Genetic Alliance. consumer health - Ovarian cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. TAXOL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1680-5 [18230721.001]
  • [Cites] J Cell Biol. 2008 Jan 28;180(2):257-60 [18227277.001]
  • [Cites] Cell. 2008 May 16;133(4):704-15 [18485877.001]
  • [Cites] Cancer Res. 2008 Jun 1;68(11):4311-20 [18519691.001]
  • [Cites] J Biol Chem. 2008 Jun 20;283(25):17635-51 [18441325.001]
  • [Cites] Cancer Immunol Immunother. 2009 Aug;58(8):1185-94 [19048252.001]
  • [Cites] J Immunol. 2002 Oct 1;169(7):3545-54 [12244144.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8 [12629218.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12561-6 [15314219.001]
  • [Cites] Cancer Res. 2005 Apr 1;65(7):2930-7 [15805296.001]
  • [Cites] BMC Cancer. 2005;5:74 [16001973.001]
  • [Cites] Br J Cancer. 2005 Sep 19;93(6):709-18 [16136053.001]
  • [Cites] Cancer Res. 2006 Apr 15;66(8):4182-90 [16618740.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9262-7 [16751266.001]
  • [Cites] Cancer Res. 2006 Jun 15;66(12):6063-71 [16778178.001]
  • [Cites] Clin Cancer Res. 2006 Nov 1;12(21):6557-64 [17085671.001]
  • [Cites] Blood. 2006 Dec 1;108(12):3906-12 [16912222.001]
  • [Cites] Nat Cell Biol. 2006 Dec;8(12):1415-23 [17115028.001]
  • [Cites] Nature. 2006 Dec 21;444(7122):1032-7 [17183313.001]
  • [Cites] Mol Cancer. 2007;6:12 [17274819.001]
  • [Cites] Dev Dyn. 2007 Mar;236(3):886-92 [17295317.001]
  • [Cites] Curr Opin Cell Biol. 2007 Apr;19(2):166-75 [17317139.001]
  • [Cites] Nat Struct Mol Biol. 2007 Apr;14(4):295-300 [17401372.001]
  • [Cites] Clin Pharmacol Ther. 2007 Jun;81(6):893-8 [17460605.001]
  • [Cites] Cancer Res. 2007 Sep 1;67(17):8378-87 [17804754.001]
  • [Cites] Nature. 2007 Sep 20;449(7160):351-5 [17721509.001]
  • [Cites] Nat Rev Genet. 2008 Feb;9(2):115-28 [18202695.001]
  • [Cites] Cell Stem Cell. 2008 Apr 10;2(4):333-44 [18397753.001]
  • (PMID = 20428807.001).
  • [ISSN] 1791-2431
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P01 CA109688; United States / NCI NIH HHS / CA / R01 CA110249; United States / NCI NIH HHS / CA / R01 CA138188
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / Antineoplastic Agents, Phytogenic; 0 / CD44 protein, human; 0 / Calcium-Binding Proteins; 0 / GLI1 protein, human; 0 / Intercellular Signaling Peptides and Proteins; 0 / Membrane Proteins; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 0 / Transcription Factors; 134324-36-0 / Serrate proteins; P88XT4IS4D / Paclitaxel
  • [Other-IDs] NLM/ NIHMS395054; NLM/ PMC3426036
  •  go-up   go-down


71. Constantinidis C, Koutalellis G, Liapis G, Stravodimos C, Alexandrou P, Adamakis I: A solitary fibrous tumor of the kidney in a 26-year-old man. Can J Urol; 2007 Jun;14(3):3583-7
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Fibrosarcoma / diagnosis. Kidney Neoplasms / diagnosis
  • [MeSH-minor] Adult. Contrast Media. Diagnosis, Differential. Humans. Male. Nephrectomy. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17594751.001).
  • [ISSN] 1195-9479
  • [Journal-full-title] The Canadian journal of urology
  • [ISO-abbreviation] Can J Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Canada
  • [Chemical-registry-number] 0 / Contrast Media
  • [Number-of-references] 26
  •  go-up   go-down


72. Dawamneh MF, Amra NK, Amr SS: Low grade fibromyxoid sarcoma: report of a case with fine needle aspiration cytology and histologic correlation. Acta Cytol; 2006 Mar-Apr;50(2):208-12

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low grade fibromyxoid sarcoma: report of a case with fine needle aspiration cytology and histologic correlation.
  • BACKGROUND: Low grade fibromyxoid sarcoma has been fully described histologically; however, the fine needle aspiration (FNA) cytologic findings are scantily defined, and the distinction from other benign and malignant soft tissue tumors can be difficult.
  • CONCLUSION: Although low grade fibromyxoid sarcoma is a rare neoplasm, it should be recognized and distinguished from other soft tissue tumors because of its low malignant potential.
  • [MeSH-major] Fibrosarcoma / diagnosis. Fibrosarcoma / pathology. Soft Tissue Neoplasms / diagnosis. Soft Tissue Neoplasms / pathology. Thoracic Neoplasms / diagnosis. Thoracic Neoplasms / pathology
  • [MeSH-minor] Adult. Biopsy, Fine-Needle / methods. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Sensitivity and Specificity. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16610692.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Mankin HJ, Hornicek FJ: Diagnosis, classification, and management of soft tissue sarcomas. Cancer Control; 2005 Jan-Feb;12(1):5-21
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis, classification, and management of soft tissue sarcomas.
  • BACKGROUND: Soft tissue sarcomas are challenging to oncologists due to their unique character, the infrequency of their occurrence, and the difficulties in predicting outcomes.
  • Patients with leiomyosarcomas, clear cell sarcomas, and malignant fibrous histiocytomas had a poorer survival rate, while those with fibrosarcomas, liposarcomas, and neurofibrosarcomas fared better.
  • [MeSH-major] Sarcoma / diagnosis. Sarcoma / therapy
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Child. Child, Preschool. Female. Fibrosarcoma / diagnosis. Fibrosarcoma / therapy. Histiocytoma, Benign Fibrous / diagnosis. Histiocytoma, Benign Fibrous / therapy. Humans. Leiomyosarcoma / diagnosis. Leiomyosarcoma / therapy. Liposarcoma / diagnosis. Liposarcoma / therapy. Male. Middle Aged. Neoplasm Staging / methods. Neurofibrosarcoma / diagnosis. Neurofibrosarcoma / therapy. Outcome Assessment (Health Care). Rhabdomyosarcoma / diagnosis. Rhabdomyosarcoma / therapy. Sarcoma, Clear Cell / diagnosis. Sarcoma, Clear Cell / therapy. Sarcoma, Synovial / diagnosis. Sarcoma, Synovial / therapy. Survival Analysis

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15668648.001).
  • [ISSN] 1073-2748
  • [Journal-full-title] Cancer control : journal of the Moffitt Cancer Center
  • [ISO-abbreviation] Cancer Control
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 205
  •  go-up   go-down


74. Koh SH, Choe HS, Lee IJ, Park HR, Bae SH: Low-grade fibromyxoid sarcoma: ultrasound and magnetic resonance findings in two cases. Skeletal Radiol; 2005 Sep;34(9):550-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade fibromyxoid sarcoma: ultrasound and magnetic resonance findings in two cases.
  • Low-grade fibromyxoid sarcoma is a rare, slow-growing, yet metastasizing neoplasm characterized by histopathological fibrous/myxoid zonal alternations, which occasionally display an intralesional multinodular appearance.
  • We report on the radiological features of two cases of low-grade fibromyxoid sarcoma.
  • [MeSH-major] Fibroma / diagnosis. Fibrosarcoma / diagnosis. Soft Tissue Neoplasms / diagnosis. Thigh. Thoracic Wall
  • [MeSH-minor] Adult. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Radiography. Ultrasonography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1992 May;183(2):341-6 [1561333.001]
  • [Cites] Ann Diagn Pathol. 2000 Aug;4(4):207-17 [10982298.001]
  • [Cites] Comput Med Imaging Graph. 1996 May-Jun;20(3):163-9 [8930469.001]
  • [Cites] BMC Surg. 2003 Sep 24;3:7 [14507419.001]
  • [Cites] Am J Surg Pathol. 1993 Jun;17(6):595-600 [8333558.001]
  • [Cites] Cancer. 1999 Apr 25;87(2):75-82 [10227597.001]
  • [Cites] Am J Clin Pathol. 1987 Nov;88(5):615-9 [3673943.001]
  • [Cites] Histopathology. 1997 Mar;30(3):274-6 [9088959.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10):1353-60 [11023096.001]
  • (PMID = 15592668.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


75. Canter RJ, Qin LX, Ferrone CR, Maki RG, Singer S, Brennan MF: Why do patients with low-grade soft tissue sarcoma die? Ann Surg Oncol; 2008 Dec;15(12):3550-60
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Why do patients with low-grade soft tissue sarcoma die?
  • INTRODUCTION: The patterns of failure and mechanisms of sarcoma-specific death are poorly characterized among the minority of patients with low-grade soft tissue sarcoma (STS) who succumb to disease.
  • In 17 patients (9%), the mechanism of sarcoma-related death could not be verified.
  • Conversely, of DODR, extremity (47%) and trunk (18%) were the most common sites, but histology was more variable [liposarcoma 35%, malignant fibrous histiocytoma (MFH) 20%, fibrosarcoma 12%, extraskeletal myxoid chondrosarcoma 10%].

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1988 Jul 1;62(1):184-93 [3383114.001]
  • [Cites] Biometrics. 1978 Dec;34(4):541-54 [373811.001]
  • [Cites] Cancer. 1984 Feb 1;53(3):530-41 [6692258.001]
  • [Cites] Int J Cancer. 1984 Jan 15;33(1):37-42 [6693192.001]
  • [Cites] J Clin Oncol. 1983 Nov;1(11):710-9 [6668489.001]
  • [Cites] World J Surg. 1988 Jun;12(3):326-31 [3400243.001]
  • [Cites] J Clin Oncol. 1992 Aug;10(8):1317-29 [1634922.001]
  • [Cites] Arch Surg. 1993 Dec;128(12):1336-43 [8250705.001]
  • [Cites] Ann Surg. 1994 Feb;219(2):165-73 [8129487.001]
  • [Cites] J Clin Oncol. 1996 Mar;14(3):869-77 [8622035.001]
  • [Cites] Cancer. 1996 May 1;77(9):1823-30 [8646680.001]
  • [Cites] J Clin Oncol. 1996 May;14(5):1679-89 [8622088.001]
  • [Cites] J Clin Oncol. 1997 Jan;15(1):350-62 [8996162.001]
  • [Cites] J Surg Oncol. 1999 Oct;72(2):77-82 [10518103.001]
  • [Cites] Cancer. 2005 Jan 15;103(2):402-8 [15578681.001]
  • [Cites] Immunol Res. 2005;32(1-3):231-45 [16106075.001]
  • [Cites] Histopathology. 2006 Jan;48(1):3-12 [16359532.001]
  • [Cites] Histopathology. 2006 Jan;48(1):42-50 [16359536.001]
  • [Cites] Cancer. 2001 May 15;91(10):1914-26 [11346874.001]
  • [Cites] J Clin Oncol. 2002 Feb 1;20(3):791-6 [11821462.001]
  • [Cites] Ann Surg. 2002 Mar;235(3):424-34 [11882765.001]
  • [Cites] Nat Immunol. 2002 Nov;3(11):991-8 [12407406.001]
  • [Cites] Cancer. 2003 May 15;97(10):2530-43 [12733153.001]
  • [Cites] Ann Surg Oncol. 2003 May;10(4):432-40 [12734093.001]
  • [Cites] Ann Surg Oncol. 2004 Jan;11(1):78-84 [14699038.001]
  • [Cites] Biometrics. 1979 Mar;35(1):25-39 [497336.001]
  • (PMID = 18830667.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / CA047179-09; United States / NCI NIH HHS / CA / P01 CA047179; United States / NCI NIH HHS / CA / P01 CA 047179; United States / NCI NIH HHS / CA / P01 CA047179-09
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS75337; NLM/ PMC2605207
  •  go-up   go-down


76. Meng GZ, Zhang HY, Bu H, Geng JG: Low-grade fibromyxoid sarcoma versus fibromatosis: a comparative study of clinicopathological and immunohistochemical features. Diagn Cytopathol; 2009 Feb;37(2):96-102
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-grade fibromyxoid sarcoma versus fibromatosis: a comparative study of clinicopathological and immunohistochemical features.
  • We have studied 11 cases of low-grade fibromyxoid sarcoma (LGFMS) and 15 cases of fibromatosis with respect to clinicopathological features and immunohistochemical expression of Ki-67, nm23, cyclinD1, and p53, in order to investigate the differential diagnosis between this two groups.
  • [MeSH-major] Fibroma / diagnosis. Fibrosarcoma / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Cyclin D1 / metabolism. Diagnosis, Differential. Female. Humans. Ki-67 Antigen / metabolism. Male. Middle Aged. NM23 Nucleoside Diphosphate Kinases / metabolism. Neoplasm Staging. Tumor Suppressor Protein p53 / metabolism. Young Adult

  • Genetic Alliance. consumer health - Fibromatosis.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19021197.001).
  • [ISSN] 1097-0339
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / NM23 Nucleoside Diphosphate Kinases; 0 / Tumor Suppressor Protein p53; 136601-57-5 / Cyclin D1; EC 2.7.4.6 / NME1 protein, human
  •  go-up   go-down


77. Wang M, Khurana RN, Parikh JG, Hidayat AA, Rao NA: Myxofibrosarcoma of the orbit: an underrecognized entity? Case report and review of the literature. Ophthalmology; 2008 Jul;115(7):1237-1240.e2
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: For historical reasons, MFS involving the orbit is likely to be underrecognized and categorized erroneously as malignant fibrous histiocytoma or other soft tissue sarcoma.
  • Although orbital MFS is an extremely rare diagnosis, ophthalmologists should be aware of the possibility and consider a diagnosis of MFS when an adult seeks treatment for an orbital tumor with aggressive growth.
  • [MeSH-major] Fibrosarcoma / pathology. Orbital Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18096231.001).
  • [ISSN] 1549-4713
  • [Journal-full-title] Ophthalmology
  • [ISO-abbreviation] Ophthalmology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


78. Tateishi U, Hasegawa T, Onaya H, Satake M, Arai Y, Moriyama N: Myxoinflammatory Fibroblastic Sarcoma: MR Appearance and Pathologic Correlation. AJR Am J Roentgenol; 2005 Jun;184(6):1749-53
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Myxoinflammatory Fibroblastic Sarcoma: MR Appearance and Pathologic Correlation.
  • OBJECTIVE: The purpose of our study was to define the MR appearance of myxoinflammatory fibroblastic sarcoma of the soft tissues and to make correlations with the histopathologic features.
  • CONCLUSION: Myxoinflammatory fibroblastic sarcoma is an uncommon malignancy that typically affects adult subjects, who present with painless swelling.
  • [MeSH-major] Fibrosarcoma / pathology. Magnetic Resonance Imaging. Myxosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15908525.001).
  • [ISSN] 0361-803X
  • [Journal-full-title] AJR. American journal of roentgenology
  • [ISO-abbreviation] AJR Am J Roentgenol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


79. Vitovskiĭ RM: [Efficacy of the surgical treatment for malignant heart tumors]. Klin Khir; 2005 Jan;(1):35-8
MedlinePlus Health Information. consumer health - Heart Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Rhabdomyosarcoma was diagnosed in 9 patients, angiosarcoma--in 11, leyomyosarcoma--in 6, malignant mixoma--in 4, fibrosarcoma, chondrosarcoma and liposarcoma--each as a single observation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15786840.001).
  • [ISSN] 0023-2130
  • [Journal-full-title] Klinichna khirurhiia
  • [ISO-abbreviation] Klin Khir
  • [Language] RUS
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Ukraine
  •  go-up   go-down


80. Sefiani S, Amarti A, Boulaadas M, Maher M, Saidi A: [Synovial sarcoma of the head and neck: two cases report]. Rev Laryngol Otol Rhinol (Bord); 2005;126(1):53-6
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Synovial sarcoma of the head and neck: two cases report].
  • Synovial sarcomas are soft tissue tumors that rarely occur in the head and neck The purpose of this report is to accrue data on this sarcoma at a rare site, and to highlight the histopathological differential diagnosis with other cervical tumors.
  • DISCUSSION: Synovial sarcomas are a rare soft tissue malignancies and the head and neck region location accounts for 3-5% of them.
  • The poor prognosis of this sarcoma justified a radical surgery with post-operative radiotherapy.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Sarcoma, Synovial / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Fibrosarcoma / pathology. Humans. Mouth Floor / pathology. Mouth Neoplasms / diagnosis. Mouth Neoplasms / pathology. Neoplasm Invasiveness. Neoplasm Recurrence, Local / pathology

  • Genetic Alliance. consumer health - Synovial sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16080650.001).
  • [ISSN] 0035-1334
  • [Journal-full-title] Revue de laryngologie - otologie - rhinologie
  • [ISO-abbreviation] Rev Laryngol Otol Rhinol (Bord)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


86. Tun K, Ozen O, Kaptanoglu E, Gurcan O, Beskonakli E, Celasun B: Primary intracranial low-grade fibromyxoid sarcoma (Evans tumor). J Clin Neurosci; 2008 Nov;15(11):1298-301

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intracranial low-grade fibromyxoid sarcoma (Evans tumor).
  • Low-grade fibromyxoid sarcoma was first described in 1987 as a rare soft tissue neoplasm characterized by a bland and deceptively benign histological appearance but with aggressive behavior.
  • The lesion was diagnosed as a low-grade fibromyxoid sarcoma.
  • Although primary intracranial low-grade fibromyxoid sarcoma has characteristic histological features, clinical and radiological correlation is necessary to make the correct diagnosis.
  • [MeSH-major] Fibrosarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Humans. Magnetic Resonance Imaging. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18771926.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


87. Wong NL, DI F: [Fine needle aspiration cytology of myxoid lesions of soft tissues: a study of 24 cases]. Zhonghua Bing Li Xue Za Zhi; 2007 Sep;36(9):619-23

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To summarize the diagnostic features of fine needle aspiration cytology (FNAC) of myxoid lesions in soft tissue, and to define the cytological criteria for differentiating benign lesions from sarcomas and between various myxoid lesions.
  • Myxoid liposarcoma, extraskeletal myxoid chondrosarcoma and myxofibrosarcoma were the most common myxoid sarcomas.
  • [MeSH-major] Biopsy, Fine-Needle / methods. Fibrosarcoma / pathology. Ganglion Cysts / pathology. Liposarcoma, Myxoid / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Bone Neoplasms / pathology. Bone Neoplasms / surgery. Chondrosarcoma / pathology. Chondrosarcoma / surgery. Diagnosis, Differential. Fasciitis / pathology. Fasciitis / surgery. Female. Humans. Male. Middle Aged. Myxoma / pathology. Myxoma / surgery. Prognosis. Sarcoma / pathology. Sarcoma / surgery. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18070452.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


88. De Ceulaer J, Magremanne M, van Veen A, Scheerlinck J: Squamous cell carcinoma recurrence around dental implants. J Oral Maxillofac Surg; 2010 Oct;68(10):2507-12
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adult. Aged. Female. Fibrosarcoma / etiology. Humans. Male. Middle Aged. Mouth Floor / pathology. Mouth Mucosa / pathology. Neoplasms, Radiation-Induced / etiology. Radiotherapy, Adjuvant / adverse effects. Time Factors. Tooth Extraction / adverse effects

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20674127.001).
  • [ISSN] 1531-5053
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dental Implants
  •  go-up   go-down


89. Higuchi M, Suzuki H, Shio Y, Hoshi S, Gotoh M: Successfully resected intrathoracic low-grade fibromyxoid sarcoma. Gen Thorac Cardiovasc Surg; 2010 Jul;58(7):348-51

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successfully resected intrathoracic low-grade fibromyxoid sarcoma.
  • A low-grade fibromyxoid sarcoma (LGFMS), an Evans tumor, is highly unusual.
  • Postoperative pathology of the resected specimen revealed the tumor to be LGFMS based on its histological appearance, immunohistological staining, and evidence of fused in sarcoma (FUS) translocation by fluorescence in situ hybridization.
  • [MeSH-major] Fibrosarcoma / surgery. Thoracic Neoplasms / surgery. Thoracotomy. Video-Assisted Surgery
  • [MeSH-minor] Biopsy, Needle. Female. Gene Expression Regulation, Neoplastic. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Neoplasm Invasiveness. Neoplasm Staging. RNA-Binding Protein FUS / genetics. Surgical Mesh. Tomography, X-Ray Computed. Translocation, Genetic. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Diagn Pathol. 2000 Aug;4(4):207-17 [10982298.001]
  • [Cites] Histopathology. 2004 Jul;45(1):29-38 [15228441.001]
  • [Cites] Lab Invest. 2005 Mar;85(3):408-15 [15640831.001]
  • [Cites] Histopathology. 1995 Mar;26(3):229-37 [7797200.001]
  • [Cites] Am J Surg Pathol. 1993 Jun;17(6):595-600 [8333558.001]
  • [Cites] Am J Clin Pathol. 1987 Nov;88(5):615-9 [3673943.001]
  • [Cites] Hum Pathol. 2008 Apr;39(4):623-8 [18275982.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10):1353-60 [11023096.001]
  • [Cites] Am J Surg Pathol. 2007 Sep;31(9):1387-402 [17721195.001]
  • (PMID = 20628852.001).
  • [ISSN] 1863-6713
  • [Journal-full-title] General thoracic and cardiovascular surgery
  • [ISO-abbreviation] Gen Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / RNA-Binding Protein FUS
  •  go-up   go-down


90. Sachdeva MP, Goldblum JR, Rubin BP, Billings SD: Low-fat and fat-free pleomorphic lipomas: a diagnostic challenge. Am J Dermatopathol; 2009 Jul;31(5):423-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adipose Tissue / pathology. Adult. Aged. Antigens, CD34 / metabolism. Diagnosis, Differential. Female. Fibrosarcoma / pathology. Giant Cell Tumors / pathology. Humans. Immunohistochemistry. Male. Middle Aged. Rosacea / pathology

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19542913.001).
  • [ISSN] 1533-0311
  • [Journal-full-title] The American Journal of dermatopathology
  • [ISO-abbreviation] Am J Dermatopathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD34
  •  go-up   go-down


91. Sharma H, Jane MJ, Reid R: Scapulo-humeral Paget's sarcoma: Scottish Bone Tumour Registry experience. Eur J Cancer Care (Engl); 2005 Sep;14(4):367-72
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Scapulo-humeral Paget's sarcoma: Scottish Bone Tumour Registry experience.
  • This study aimed to analyse the clinical, radiological and histological features of 16 scapulo-humeral Paget's sarcoma cases accrued from Scottish Bone Tumour Registry between January 1950 and December 2000.
  • Histology showed predominantly osteosarcoma (n = 12), followed by pleomorphic sarcoma (n = 2), malignant fibrous histiocytoma (n = 1) and fibrosarcoma (n = 1).
  • In summary, Paget's sarcoma of the scapulo-humeral area presents with progressively worsening pain, a painful mass with or without a pathological fracture, predominantly lytic in humeral and purely sclerotic in scapular lesions, osteosarcoma-dominant histology, primarily treated with an early limb ablative surgery and associated with a poor 1-year survival (12.5%) and 5-year survival (6.2%) rate.
  • [MeSH-minor] Adult. Aged. Female. Humans. Humeral Fractures / pathology. Humeral Fractures / radiography. Humeral Fractures / surgery. Male. Middle Aged. Pain / physiopathology. Registries. Scotland. Survival Analysis

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Paget's Disease of Bone.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16098122.001).
  • [ISSN] 0961-5423
  • [Journal-full-title] European journal of cancer care
  • [ISO-abbreviation] Eur J Cancer Care (Engl)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


92. Heletz I, Abramson SV: Large obstructive cardiac myxofibrosarcoma is nearly invisible on transthoracic echocardiogram. Echocardiography; 2009 Aug;26(7):847-51

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Malignant primary cardiac tumors are exceptionally rare, and the most common of these are sarcomas.
  • [MeSH-major] Echocardiography / methods. Fibrosarcoma / ultrasonography. Heart Atria / ultrasonography. Heart Neoplasms / ultrasonography
  • [MeSH-minor] Adult. Diagnostic Errors / prevention & control. False Negative Reactions. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19490014.001).
  • [ISSN] 1540-8175
  • [Journal-full-title] Echocardiography (Mount Kisco, N.Y.)
  • [ISO-abbreviation] Echocardiography
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


93. Chidzonga MM, Mahomva L: Sarcomas of the oral and maxillofacial region: a review of 88 cases in Zimbabwe. Br J Oral Maxillofac Surg; 2007 Jun;45(4):317-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sarcomas of the oral and maxillofacial region: a review of 88 cases in Zimbabwe.
  • We reviewed the case notes of 88 patients who were treated for sarcomas of the oral and maxillofacial region over a period of 24 years.
  • [MeSH-major] Jaw Neoplasms / epidemiology. Sarcoma / epidemiology
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Child. Female. Fibrosarcoma / epidemiology. Humans. Male. Mandibular Neoplasms / epidemiology. Maxillary Neoplasms / epidemiology. Middle Aged. Osteosarcoma / epidemiology. Retrospective Studies. Rhabdomyosarcoma / epidemiology. Sex Factors. Zimbabwe / epidemiology

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16386339.001).
  • [ISSN] 0266-4356
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


94. De Corti F, Dall'Igna P, Bisogno G, Casara D, Rossi CR, Foletto M, Alaggio R, Carli M, Cecchetto G: Sentinel node biopsy in pediatric soft tissue sarcomas of extremities. Pediatr Blood Cancer; 2009 Jan;52(1):51-4
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sentinel node biopsy in pediatric soft tissue sarcomas of extremities.
  • BACKGROUND: Sentinel Node Biopsy is an established staging technique in many adult malignancies.
  • Our experience with sentinel node biopsy in soft tissue sarcomas of extremities in children is reported.
  • The diagnosis was rhabdomyosarcoma in 5 and other soft tissue sarcomas in 12: Ewing/PNET sarcoma 6, epithelioid sarcoma 1, malignant peripheral-nerve-sheath tumor 1, undifferentiated sarcoma 1, myxoid liposarcoma 2, adult-type fibrosarcoma 1.
  • Nodes were positive for metastasis in two patients with alveolar rhabdomyosarcoma and undifferentiated sarcoma.
  • It could be an alternative to aggressive or random biopsies for extremity rhabdomyosarcoma and it can contribute to define those non-rhabdomyosarcoma soft tissue sarcomas that spread to regional nodes.
  • [MeSH-minor] Adolescent. Child. Child, Preschool. Female. Humans. Male. Neoplasm Metastasis / pathology. Sentinel Lymph Node Biopsy. Soft Tissue Neoplasms / pathology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18819127.001).
  • [ISSN] 1545-5017
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


95. Fujibayashi S, Neo M, Takemoto M, Ota M, Nakayama T, Toguchida J, Nakamura T: Computer-assisted spinal osteotomy: a technical note and report of four cases. Spine (Phila Pa 1976); 2010 Aug 15;35(18):E895-903
MedlinePlus Health Information. consumer health - Ankylosing Spondylitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adult. Carcinoma, Hepatocellular / surgery. Chondrosarcoma / surgery. Female. Fibrosarcoma / surgery. Humans. Male. Middle Aged. Spinal Curvatures / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21381258.001).
  • [ISSN] 1528-1159
  • [Journal-full-title] Spine
  • [ISO-abbreviation] Spine
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Berkmann S, Tolnay M, Hänggi D, Ghaffari A, Gratzl O: Sarcoma of the sella after radiotherapy for pituitary adenoma. Acta Neurochir (Wien); 2010 Oct;152(10):1725-35
MedlinePlus Health Information. consumer health - Radiation Therapy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sarcoma of the sella after radiotherapy for pituitary adenoma.
  • We report the illustrative case of a 38-year-old man with acromegaly who had transsphenoidal surgery and radiotherapy 7 years before presenting with a sellar high-grade sarcoma.
  • We performed a thorough search of the literature and reviewed numerous publications and reports on primary and secondary sarcomas of the sella.
  • For further analysis, we identified and selected a group of patients based on the criteria for studying radiation-induced tumors as described by Cahan.Compared to the surgically treated group, secondary sarcomas of the sella are more frequent in patients who have had radiotherapy.
  • Radiation-induced sarcoma is a rare sequela of pituitary radiotherapy.
  • It is important for the treating physician to keep in mind the possibility of post-radiation sarcoma development.
  • [MeSH-major] Adenoma / radiotherapy. Fibrosarcoma / etiology. Fibrosarcoma / pathology. Pituitary Neoplasms / radiotherapy. Radiotherapy / adverse effects. Skull Base Neoplasms / etiology. Skull Base Neoplasms / pathology
  • [MeSH-minor] Adult. Humans. Male. Spinal Cord Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20512596.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


97. Ballardini P, Gulmini L, Margutti G, Lelli G: Mesenteric fibromatosis in a patient with Camurati-Engelmann disease. A case report and literature review. Tumori; 2005 Nov-Dec;91(6):552-4
The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for camurati-engelmann disease .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In view of these characteristics it may be considered a low-grade fibrosarcoma.
  • [MeSH-minor] Adult. Humans. Inflammatory Bowel Diseases / complications. Male

  • Genetic Alliance. consumer health - Camurati Engelmann Disease.
  • Genetic Alliance. consumer health - Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16457156.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 21
  •  go-up   go-down


98. Elco CP, Mariño-Enríquez A, Abraham JA, Dal Cin P, Hornick JL: Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: report of a case providing further evidence for a pathogenetic link. Am J Surg Pathol; 2010 Nov;34(11):1723-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: report of a case providing further evidence for a pathogenetic link.
  • Myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor are rare, slow-growing soft tissue tumors of the distal extremities with recurrent potential.
  • Here we report a case of a 42-year-old female with a soft tissue tumor of the ankle showing hybrid morphologic features of myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor, a der(10)t(1;10), and abnormalities of chromosome 3.
  • [MeSH-major] Chromosomes, Human. Fibrosarcoma / genetics. Hemosiderosis / genetics. Lipoma / genetics. Soft Tissue Neoplasms / genetics
  • [MeSH-minor] Adult. Ankle. Biopsy. Chromosome Aberrations. Chromosomes, Human, Pair 1. Chromosomes, Human, Pair 10. Chromosomes, Human, Pair 3. Female. Humans. Karyotyping. Magnetic Resonance Imaging. Neoadjuvant Therapy. Orthopedic Procedures. Radiotherapy, Adjuvant. Translocation, Genetic. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20871391.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


99. Maeda E, Ohta S, Watadani T, Goto A, Nakajima A, Ohtomo K: Imaging findings of thoracic low-grade fibromyxoid sarcoma: report of three cases. Jpn J Radiol; 2009 Nov;27(9):375-80

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imaging findings of thoracic low-grade fibromyxoid sarcoma: report of three cases.
  • Imaging findings of low-grade fibromyxoid sarcoma (LGFMS) are reported in three thoracic cases, two in the mediastinum and one in the chest wall.
  • [MeSH-major] Fibrosarcoma / diagnostic imaging. Fibrosarcoma / pathology. Soft Tissue Neoplasms / diagnostic imaging. Soft Tissue Neoplasms / pathology. Thoracic Neoplasms / diagnostic imaging. Thoracic Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Contrast Media. Female. Follow-Up Studies. Humans. Image Enhancement / methods. Magnetic Resonance Imaging / methods. Male. Mediastinum / diagnostic imaging. Mediastinum / pathology. Mediastinum / surgery. Middle Aged. Thoracic Wall / diagnostic imaging. Thoracic Wall / pathology. Thoracic Wall / surgery. Tomography, X-Ray Computed / methods. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Pathol Lab Med. 2006 Sep;130(9):1358-60 [16948525.001]
  • [Cites] Pediatr Radiol. 2009 Apr;39(4):396-9 [19205685.001]
  • [Cites] Radiat Med. 2006 Aug;24(7):511-4 [17058145.001]
  • [Cites] Radiat Med. 2008 May;26(4):244-7 [18509725.001]
  • [Cites] Clinics (Sao Paulo). 2006 Jun;61(3):267-70 [16832560.001]
  • [Cites] J Thorac Imaging. 2005 Nov;20(4):294-7 [16282909.001]
  • [Cites] Skeletal Radiol. 2005 Sep;34(9):550-4 [15592668.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10):1353-60 [11023096.001]
  • [Cites] J Thorac Cardiovasc Surg. 1999 Nov;118(5):970-1 [10534712.001]
  • (PMID = 19943150.001).
  • [ISSN] 1867-108X
  • [Journal-full-title] Japanese journal of radiology
  • [ISO-abbreviation] Jpn J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


100. Marchetti C, Bianchi A, Mazzoni S, Cipriani R, Campobassi A: Oromandibular reconstruction using a fibula osteocutaneous free flap: four different "preplating" techniques. Plast Reconstr Surg; 2006 Sep;118(3):643-51
MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Adolescent. Adult. Bone Plates. Bone Screws. Carcinoma, Adenoid Cystic / surgery. Cephalometry. Esthetics. Fibrosarcoma / surgery. Humans. Lymphoma, Non-Hodgkin / surgery. Male. Mandibular Diseases / surgery. Middle Aged. Neoplasm Invasiveness. Osteitis / surgery. Osteosarcoma / surgery. Osteotomy. Transplantation, Heterotopic

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16932172.001).
  • [ISSN] 1529-4242
  • [Journal-full-title] Plastic and reconstructive surgery
  • [ISO-abbreviation] Plast. Reconstr. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement